| ID |
Reference |
| F.4514 |
Adam, S., Almeida, M.F., Assoun, M., Baruteau, J., Bernabei, S.M., Bigot, S., Champion, H., Daly, A., Dassy, M., Dawson, S., Dixon, M., Dokoupil, K., Dubois, S., Dunlop, C., Evans, S., Eyskens, F., Faria, A., Favre, E., Ferguson, C., Goncalves, C., Gribben, J., Heddrich-Ellerbrok, M., Jankowski, C., Janssen-Regelink, R., Jouault, C., Laguerre, C., Le Verge, S., Link, R., Lowry, S., Luyten, K., Macdonald, A., Maritz, C., McDowell, S., Meyer, U., Micciche, A., Robert, M., Robertson, L.V., Rocha, J.C., Rohde, C., Saruggia, I., Sjoqvist, E., Stafford, J., Terry, A., Thom, R., Vande Kerckhove, K., van Rijn, M., van Teeffelen-Heithoff, A., Wegberg, A.v., van Wyk, K., Vasconcelos, C., Vestergaard, H., Webster, D., White, F.J., Wildgoose, J., & Zweers, H. (Dec 2013). Dietary management of urea cycle disorders: European practice. Mol Genet Metab, 110, 439-45. doi:10.1016/j.ymgme.2013.09.003 |
| F.7965 |
Additional individual contributors from E-IMD, Molema, F., Gleich, F., Burgard, P., van der Ploeg, A.T., Summar, M.L., Chapman, K.A., Barić, I., Lund, A.M., Kölker, S., & Williams, M. (Nov 2019). Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: On the basis of information from a European multicenter registry. J Inherit Metab Dis, 42, 1162-1175. doi:10.1002/jimd.12066 |
| F.7964 |
Additional individual contributors from E-IMD, Molema, F., Gleich, F., Burgard, P., van der Ploeg, A.T., Summar, M.L., Chapman, K.A., Lund, A.M., Rizopoulos, D., Kölker, S., & Williams, M. (Apr 2019). Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment. Mol Genet Metab, 126, 397-405. doi:10.1016/j.ymgme.2019.02.003 |
| F.4803 |
Additional individual contributors of the E-IMD consortium, Posset, R., Garcia-Cazorla, A., Valayannopoulos, V., Teles, E.L., Dionisi-Vici, C., Brassier, A., Burlina, A.B., Burgard, P., Cortès-Saladelafont, E., Dobbelaere, D., Couce, M.L., Sykut-Cegielska, J., Häberle, J., Lund, A.M., Chakrapani, A., Schiff, M., Walter, J.H., Zeman, J., Vara, R., & Kölker, S. (Sep 2016). Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders. J Inherit Metab Dis, 39, 661-672. doi:10.1007/s10545-016-9938-9 |
| F.5156 |
Ah Mew, N., McCarter, R., Daikhin, Y., Lichter-Konecki, U., Nissim, I., Yudkoff, M., & Tuchman, M. (Aug 2014). Augmenting ureagenesis in patients with partial carbamyl phosphate synthetase 1 deficiency with N-carbamyl-L-glutamate. J Pediatr, 165, 401-403.e3. doi:10.1016/j.jpeds.2014.04.012 |
| F.5171 |
Akyol, Ş., Yılmaz, Ş., Tüfekçi, Ö., Arslan, N., & Ören, H. (Dec 2022). A complication of lysinuric protein intolerance: Intermittent haemophagocytic lymphohistiocytosis. J Paediatr Child Health, 58, 2300-2301. doi:10.1111/jpc.16158 |
| F.5177 |
Alameri, M., Shakra, M., & Alsaadi, T. (Nov 2015). Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report. J Med Case Rep, 9, 267. doi:10.1186/s13256-015-0741-2 |
| F.5203 |
Anadiotis, G., Ierardi-Curto, L., Kaplan, P.B., & Berry, G.T. (Jan 2001). Ornithine transcarbamylase deficiency and pancreatitis. J Pediatr, 138, 123-4. doi:10.1067/mpd.2001.109792 |
| F.5219 |
Aoki, M., Fukao, T., Fujita, Y., Watanabe, M., Teramoto, T., Kato, Y., Suzuki, Y., & Kondo, N. (Aug 2001). Lysinuric protein intolerance in siblings: complication of systemic lupus erythematosus in the elder sister. Eur J Pediatr, 160, 522-3. doi:10.1007/pl00008455 |
| F.5232 |
Arn, P.H., Hauser, E.R., Thomas, G.H., Herman, G., Hess, D., & Brusilow, S.W. (Jun 1990). Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma. N Engl J Med, 322, 1652-5. doi:10.1056/NEJM199006073222307 |
| F.5235 |
Aronson, P.L., & Mistry, R.D. (Jun 2011). Ornithine transcarbamylase deficiency presenting as hepatitis. Pediatr Emerg Care, 27, 527-9. doi:10.1097/PEC.0b013e31821d86c1 |
| F.5255 |
Avdjieva-Tzavella, D.M., Ivanova, M.B., Todorov, T.P., Todorova, A.P., Panteleeva, E.I., Tincheva, S.S., Lazarova, E.A., Kathom, H.M., Yaneva, P.G., & Tincheva, R.S. (2014). First Bulgarian case of citrin deficiency caused by one novel and one recurrent mutation in the SLC25A13 gene. Genet Couns, 25(3):271-6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25365849 |
| F.5271 |
Bachmann, C. (Jun 2003). Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr, 162, 410-6. doi:10.1007/s00431-003-1188-9 |
| F.5284 |
Baertling, F., Wagner, M., Brunet, T., Sabir, H., Wieczorek, D., Meitinger, T., Meissner, T., & Distelmaier, F. (Mar 2020). Fatal metabolic decompensation in carbonic anhydrase VA deficiency despite early treatment and control of hyperammonemia. Genet Med, 22, 654-655. doi:10.1038/s41436-019-0677-9 |
| F.5287 |
Bailly, P., Noury, J.B., Timsit, S., & Ben Salem, D. (Nov 2015). Teaching NeuroImages: Ornithine transcarbamylase deficiency revealed by a coma in a pregnant woman. Neurology, 85, e146-7. doi:10.1212/WNL.0000000000002131 |
| F.5290 |
Bakhiet, M., AlAwadi, A.M.I., AlHammadi, M.M., Ali, M.F., & Butti, N. (May 2018). A case report of neurological complications owing to lately diagnosed hyperargininemia emphasizing the role of national neonatal screening policies in the kingdom of Bahrain. Medicine (Baltimore), 97, e10780. doi:10.1097/MD.0000000000010780 |
| F.5292 |
Bakirtzis, C., Smyrni, N., Afrantou, T., Boziki, M.K., & Grigoriadis, N. (Sep 2021). Spastic gait, intellectual disability and seizures due to a rare mutation causing hyperargininemia. Clin Neurol Neurosurg, 208, 106895. doi:10.1016/j.clineuro.2021.106895 |
| F.5293 |
Bakker, H.D., Abeling, N.G., van Schooneveld, M.J., Wanders, R.J., & van Gennip, A.H. (1991). A far advanced case of gyrate atrophy in a 12-year-old girl. J Inherit Metab Dis, 14, 379-81. doi:10.1007/BF01811708 |
| F.5305 |
Ban, K., Sugiyama, N., Sugiyama, K., Wada, Y., Suzuki, T., Hashimoto, T., & Kobayashi, K. (May 2001). A pediatric patient with classical citrullinemia who underwent living-related partial liver transplantation. Transplantation, 71, 1495-7. doi:10.1097/00007890-200105270-00026 |
| F.5308 |
Baranello, G., Alfei, E., Martinelli, D., Rizzetto, M., Cazzaniga, F., Dionisi-Vici, C., Gellera, C., & Castellotti, B. (Sep 2014). Hyperargininemia: 7-month follow-up under sodium benzoate therapy in an Italian child presenting progressive spastic paraparesis, cognitive decline, and novel mutation in ARG1 gene. Pediatr Neurol, 51, 430-3. doi:10.1016/j.pediatrneurol.2014.05.029 |
| F.5322 |
Baruteau, J., Jameson, E., Morris, A.A., Chakrapani, A., Santra, S., Vijay, S., Kocadag, H., Beesley, C.E., Grunewald, S., Murphy, E., Cleary, M., Mundy, H., Abulhoul, L., Broomfield, A., Lachmann, R., Rahman, Y., Robinson, P.H., MacPherson, L., Foster, K., Chong, W.K., Ridout, D.A., Bounford, K.M., Waddington, S.N., Mills, P.B., Gissen, P., & Davison, J.E. (May 2017). Expanding the phenotype in argininosuccinic aciduria: need for new therapies. J Inherit Metab Dis, 40, 357-368. doi:10.1007/s10545-017-0022-x |
| F.5334 |
Batshaw, M.L., Brusilow, S., Waber, L., Blom, W., Brubakk, A.M., Burton, B.K., Cann, H.M., Kerr, D., Mamunes, P., Matalon, R., Myerberg, D., & Schafer, I.A. (Jun 1982). Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med, 306, 1387-92. doi:10.1056/NEJM198206103062303 |
| F.5525 |
Batshaw, M.L., Msall, M., Beaudet, A.L., & Trojak, J. (Feb 1986). Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency. J Pediatr, 108, 236-41. doi:10.1016/s0022-3476(86)80989-1 |
| F.4594 |
Bélanger-Quintana, A., Arrieta Blanco, F., Barrio-Carreras, D., Bergua Martínez, A., Cañedo Villarroya, E., García-Silva, M.T., Lama More, R., Martín-Hernández, E., López, A.M., Morales-Conejo, M., Pedrón-Giner, C., Quijada-Fraile, P., Stanescu, S., & Casanova, M.M. (Jul 2022). Recommendations for the Diagnosis and Therapeutic Management of Hyperammonaemia in Paediatric and Adult Patients. Nutrients, 14, . doi:10.3390/nu14132755 |
| F.4597 |
Bölsterli, B.K., Boltshauser, E., Palmieri, L., Spenger, J., Brunner-Krainz, M., Distelmaier, F., Freisinger, P., Geis, T., Gropman, A.L., Häberle, J., Hentschel, J., Jeandidier, B., Karall, D., Keren, B., Klabunde-Cherwon, A., Konstantopoulou, V., Kottke, R., Lasorsa, F.M., Makowski, C., Mignot, C., O'Gorman Tuura, R., Porcelli, V., Santer, R., Sen, K., Steinbrücker, K., Syrbe, S., Wagner, M., Ziegler, A., Zöggeler, T., Mayr, J.A., Prokisch, H., & Wortmann, S.B. (Aug 2022). Ketogenic Diet Treatment of Defects in the Mitochondrial Malate Aspartate Shuttle and Pyruvate Carrier. Nutrients, 14, . doi:10.3390/nu14173605 |
| F.4598 |
Bösch, F., Landolt, M.A., Baumgartner, M.R., Zeltner, N., Kölker, S., Gleich, F., Burlina, A., Cazzorla, C., Packman, W., V D Schwartz, I., Vieira Neto, E., Ribeiro, M.G., Martinelli, D., Olivieri, G., & Huemer, M. (Jan 2021). Health-related quality of life in paediatric patients with intoxication-type inborn errors of metabolism: Analysis of an international data set. J Inherit Metab Dis, 44, 215-225. doi:10.1002/jimd.12301 |
| F.4600 |
Büyüktortop, N., Alp, M.N., Sivri, S., Coşkun, T., & Kural, G. (2011). Gyrate atrophy of the choroid and retina: a case report. Turk J Pediatr, 53(1):94-6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21534348 |
| F.4603 |
Beck, N.M., Johnston, J.P., Lemke, K.S., Pogacar, P., & Phornphutkul, C. (May 2011). Rhode Island metabolic newborn screening: the effect of early identification. A case report of argininosuccinic aciduria (ASA). Med Health R I, 94(5):121-3. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21710918 |
| F.4649 |
Bell, L., McInnes, R.R., Arshinoff, S.A., & McCulloch, J.C. (Aug 1981). Dietary treatment of hyperornithinemia in gyrate atrophy. J Am Diet Assoc, 79(2):139-44. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7252022 |
| F.4655 |
Ben-Ari, Z., Dalal, A., Morry, A., Pitlik, S., Zinger, P., Cohen, J., Fattal, I., Galili-Mosberg, R., Tessler, D., Baruch, R.G., Nuoffer, J.M., Largiader, C.R., & Mandel, H. (Feb 2010). Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' diet. J Hepatol, 52, 292-5. doi:10.1016/j.jhep.2009.11.014 |
| F.4663 |
Bennett, E.E., Hummel, K., Smith, A.G., & Longo, N. (Jan 2019). Acute Presentation and Management of the Encephalopathic Child With an Undiagnosed Inborn Error of Metabolism. J Emerg Med, 56, e5-e8. doi:10.1016/j.jemermed.2018.09.037 |
| F.4677 |
Bergmann, K.R., McCabe, J., Smith, T.R., Guillaume, D.J., Sarafoglou, K., & Gupta, S. (Apr 2014). Late-onset ornithine transcarbamylase deficiency: treatment and outcome of hyperammonemic crisis. Pediatrics, 133, e1072-6. doi:10.1542/peds.2013-1324 |
| F.4691 |
Berry, G.T., & Steiner, R.D. (Jan 2001). Long-term management of patients with urea cycle disorders. J Pediatr, 138, S56-60; discussion S60-1. doi:10.1067/mpd.2001.111837 |
| F.4703 |
Berry, S.A., Lichter-Konecki, U., Diaz, G.A., McCandless, S.E., Rhead, W., Smith, W., Lemons, C., Nagamani, S.C., Coakley, D.F., Mokhtarani, M., Scharschmidt, B.F., & Lee, B. (May 2014). Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes. Mol Genet Metab, 112, 17-24. doi:10.1016/j.ymgme.2014.02.007 |
| F.4708 |
Berson, E.L., Hanson, A.H., Rosner, B., & Shih, V.E. (1982). A two year trial of low protein, low arginine diets or vitamin B6 for patients with gyrate atrophy. Birth Defects Orig Artic Ser, 18(6):209-18. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/6756498 |
| F.4709 |
Berson, E.L., Shih, V.E., & Sullivan, P.L. (Apr 1981). Ocular findings in patients with gyrate atrophy on pyridoxine and low-protein, low-arginine diets. Ophthalmology, 88, 311-5. doi:10.1016/s0161-6420(81)35029-5 |
| F.4724 |
Bijarnia-Mahay, S., Jain, V., Bansal, R.K., Reddy, G.M., & Haberle, J. (Aug 2016). Lysinuric Protein Intolerance Presenting with Recurrent Hyperammonemic Encephalopathy. Indian Pediatr, 53, 732-4. doi:10.1007/s13312-016-0920-2 |
| F.4726 |
Bilgin, L., Unal, S., Gunduz, M., Uncu, N., & Tiryaki, T. (Jul 2014). Utility of peritoneal dialysis in neonates affected by inborn errors of metabolism. J Paediatr Child Health, 50, 531-5. doi:10.1111/jpc.12510 |
| F.4727 |
Bin Sawad, A., Jackimiec, J., Bechter, M., Hull, M., Yeaw, J., Wang, Y., & Diaz, G.A. (2022). Health care resource utilization in the management of patients with Arginase 1 Deficiency in the US: a retrospective, observational, claims database study. J Med Econ, 25, 848-856. doi:10.1080/13696998.2022.2089517 |
| F.4728 |
Bin Sawad, A., Jackimiec, J., Bechter, M., Trucillo, A., Lindsley, K., Bhagat, A., Uyei, J., & Diaz, G.A. (2022). Epidemiology, methods of diagnosis, and clinical management of patients with arginase 1 deficiency (ARG1-D): A systematic review. Mol Genet Metab, 137, 153-163. doi:10.1016/j.ymgme.2022.08.005 |
| F.4737 |
Blair, N.F., Cremer, P.D., & Tchan, M.C. (Feb 2015). Urea cycle disorders: a life-threatening yet treatable cause of metabolic encephalopathy in adults. Pract Neurol, 15, 45-8. doi:10.1136/practneurol-2014-000916 |
| F.4753 |
Boles, R.G., & Stone, M.L. (Dec 2006). A patient with arginase deficiency and episodic hyperammonemia successfully treated with menses cessation. Mol Genet Metab, 89, 390-1. doi:10.1016/j.ymgme.2006.07.012 |
| F.4756 |
Boneh, A. (2014). Dietary protein in urea cycle defects: How much? Which? How?. Mol Genet Metab, 113, 109-12. doi:10.1016/j.ymgme.2014.04.009 |
| F.4772 |
Braga, A.C., Vilarinho, L., Ferreira, E., & Rocha, H. (Feb 1997). Hyperargininemia presenting as persistent neonatal jaundice and hepatic cirrhosis. J Pediatr Gastroenterol Nutr, 24, 218-21. doi:10.1097/00005176-199702000-00018 |
| F.7968 |
Brambilla, A., Bianchi, M.L., Cancello, R., Galimberti, C., Gasperini, S., Pretese, R., Rigoldi, M., Tursi, S., & Parini, R. (Nov 2019). Resting energy expenditure in argininosuccinic aciduria and in other urea cycle disorders. J Inherit Metab Dis, 42, 1105-1117. doi:10.1002/jimd.12108 |
| G.189 |
Branov J (2021) Vancouver General Hospital Adult Metabolic Clinic Urea Cycle Disorders Protocol for Dietitians. Adult Metabolic Diseases Clinic, Vancouver BC. |
| F.4776 |
Brassier, A., Gobin, S., Arnoux, J.B., Valayannopoulos, V., Habarou, F., Kossorotoff, M., Servais, A., Barbier, V., Dubois, S., Touati, G., Barouki, R., Lesage, F., Dupic, L., Bonnefont, J.P., Ottolenghi, C., & De Lonlay, P. (May 2015). Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients. Orphanet J Rare Dis, 10, 58. doi:10.1186/s13023-015-0266-1 |
| F.4783 |
British Inherited Metabolic Diseases Group (BIMDG) Dietitian’s Group, Adam, S., Champion, H., Daly, A., Dawson, S., Dixon, M., Dunlop, C., Eardley, J., Evans, S., Ferguson, C., Jankowski, C., Lowry, S., MacDonald, A., Maritz, C., Micciche, A., Robertson, L., Stafford, J., Terry, A., Thom, R., van Wyk, K., Webster, D., White, F.J., & Wildgoose, J. (Aug 2012). Dietary management of urea cycle disorders: UK practice. J Hum Nutr Diet, 25, 398-404. doi:10.1111/j.1365-277X.2012.01259.x |
| F.4722 |
Brusilow, S.W., & Finkelstien, J. (Oct 1993). Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency. Metabolism, 42, 1336-9. doi:10.1016/0026-0495(93)90135-b |
| F.4707 |
Brusilow, S.W., & Maestri, N.E. (1996). Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr, 43:127-70. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8794176 |
| F.4674 |
Burlina, A.B., Ogier, H., Korall, H., & Trefz, F.K. (Apr 2001). Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients. Mol Genet Metab, 72, 351-5. doi:10.1006/mgme.2001.3156 |
| F.4662 |
Burton, B.K. (Nov 2000). Urea cycle disorders. Clin Liver Dis, 4, 815-30, vi. doi:10.1016/s1089-3261(05)70143-4 |
| F.4640 |
Cai, X., Yu, D., Xie, Y., & Zhou, H. (Feb 2018). Argininemia as a cause of severe chronic stunting and partial growth hormone deficiency (PGHD): A case report. Medicine (Baltimore), 97, e9880. doi:10.1097/MD.0000000000009880 |
| F.4633 |
Caldovic, L., Morizono, H., Daikhin, Y., Nissim, I., McCarter, R.J., Yudkoff, M., & Tuchman, M. (Oct 2004). Restoration of ureagenesis in N-acetylglutamate synthase deficiency by N-carbamylglutamate. J Pediatr, 145, 552-4. doi:10.1016/j.jpeds.2004.06.047 |
| F.4619 |
Canadian Inherited Metabolic Diseases Research Network (CIMDRN), Siddiq, S., Wilson, B.J., Graham, I.D., Lamoureux, M., Khangura, S.D., Tingley, K., Tessier, L., Chakraborty, P., Coyle, D., Dyack, S., Gillis, J., Greenberg, C., Hayeems, R.Z., Jain-Ghai, S., Kronick, J.B., Laberge, A.M., Little, J., Mitchell, J.J., Prasad, C., Siriwardena, K., Sparkes, R., Speechley, K.N., Stockler, S., Trakadis, Y., Wafa, S., Walia, J., Wilson, K., Yuskiv, N., & Potter, B.K. (Dec 2016). Experiences of caregivers of children with inherited metabolic diseases: a qualitative study. Orphanet J Rare Dis, 11, 168. doi:10.1186/s13023-016-0548-2 |
| F.4610 |
Cardenas, J.F., & Bodensteiner, J.B. (Jul 2009). Osmotic demyelination syndrome as a consequence of treating hyperammonemia in a patient with ornithine transcarbamylase deficiency. J Child Neurol, 24, 884-6. doi:10.1177/0883073808331349 |
| F.5339 |
Carpenter, T.O., Levy, H.L., Holtrop, M.E., Shih, V.E., & Anast, C.S. (Jan 1985). Lysinuric protein intolerance presenting as childhood osteoporosis. Clinical and skeletal response to citrulline therapy. N Engl J Med, 312, 290-4. doi:10.1056/NEJM198501313120506 |
| F.5341 |
Cartagena, A., Prasad, A.N., Rupar, C.A., Strong, M., Tuchman, M., Ah Mew, N., & Prasad, C. (Jan 2013). Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults. Can J Neurol Sci, 40, 3-9. doi:10.1017/s0317167100012877 |
| F.5359 |
Cavicchi, C., Chilleri, C., Fioravanti, A., Ferri, L., Ripandelli, F., Costa, C., Calabresi, P., Prontera, P., Pochiero, F., Pasquini, E., Funghini, S., la Marca, G., Donati, M.A., & Morrone, A. (Jan 2018). Late-Onset N-Acetylglutamate Synthase Deficiency: Report of a Paradigmatic Adult Case Presenting with Headaches and Review of the Literature. Int J Mol Sci, 19, . doi:10.3390/ijms19020345 |
| F.5546 |
Cavicchi, C., Donati, M., Parini, R., Rigoldi, M., Bernardi, M., Orfei, F., Gentiloni Silveri, N., Colasante, A., Funghini, S., Catarzi, S., Pasquini, E., la Marca, G., Mooney, S., Guerrini, R., & Morrone, A. (Jul 2014). Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment. Orphanet J Rare Dis, 9, 105. doi:10.1186/s13023-014-0105-9 |
| F.5360 |
Cazzorla, C., Del Rizzo, M., Burgard, P., Zanco, C., Bordugo, A., Burlina, A.B., & Burlina, A.P. (May 2012). Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases. Mol Genet Metab, 106, 25-30. doi:10.1016/j.ymgme.2012.02.008 |
| F.5364 |
Cederbaum, J.A., LeMons, C., Rosen, M., Ahrens, M., Vonachen, S., & Cederbaum, S.D. (Jan 2001). Psychosocial issues and coping strategies in families affected by urea cycle disorders. J Pediatr, 138, S72-80. doi:10.1067/mpd.2001.111839 |
| F.5405 |
Celik, M., Akdeniz, O., & Ozgun, N. (Mar 2019). Efficacy of peritoneal dialysis in neonates presenting with hyperammonaemia due to urea cycle defects and organic acidaemia. Nephrology (Carlton), 24, 330-335. doi:10.1111/nep.13224 |
| F.5435 |
Chen, C.Y., Tsai, T.C., Lee, W.J., & Chen, H.C. (2007). Aminograms during continuous hemodiafiltration in the treatment of hyperammonemia due to ornithine transcarbamylase deficiency. Ren Fail, 29, 661-5. doi:10.1080/08860220701459618 |
| F.5496 |
Chew, H.B., Ngu, L.H., Zabedah, M.Y., Keng, W.T., Balasubramaniam, S., Hanifah, M.J., & Kobayashi, K. (Dec 2010). Neonatal intrahepatic cholestasis associated with citrin deficiency (NICCD): a case series of 11 Malaysian patients. J Inherit Metab Dis, 33 Suppl 3, S489-95. doi:10.1007/s10545-010-9248-6 |
| F.5497 |
Choi, D.E., Lee, K.W., Shin, Y.T., & Na, K.R. (May 2012). Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency. J Korean Med Sci, 27, 556-9. doi:10.3346/jkms.2012.27.5.556 |
| F.5533 |
Choi, J.J., Kim, H.S., Lee, K.C., Shin, Y., & Jo, Y.Y. (Oct 2016). Anesthetic experience of an adult male with citrullinemia type II: a case report. BMC Anesthesiol, 16, 92. doi:10.1186/s12871-016-0253-7 |
| F.5548 |
Choi, Y., Oh, A., Lee, Y., Kim, G.H., Choi, J.H., Yoo, H.W., & Lee, B.H. (Feb 2022). Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency. Clin Chim Acta, 526, 55-61. doi:10.1016/j.cca.2021.11.029 |
| F.5553 |
Christopher, R., Babu, S.V., & Shetty, K.T. (Jul 1999). Hyperornithinaemia associated with gyrate atrophy of the choroid and retina: two cases from India. Ann Clin Biochem, 36 ( Pt 4), 519-22. doi:10.1177/000456329903600419 |
| F.5519 |
Clarkston, K., Lee, J., Donoghue, S., Peters, H., Eiroa, H., Shah, A.A., Loomes, K., Wen, J., Oliver, M., Hardikar, W., Prada, C.E., & Asai, A. (Mar 2021). Acute liver dysfunction with delayed peak of serum aminotransferase levels as a presentation of ornithine transcarbamylase deficiency in females. Am J Med Genet A, 185, 909-915. doi:10.1002/ajmg.a.62031 |
| F.5501 |
Collins, F.S., Summer, G.K., Schwartz, R.P., & Parke, J.C. (Mar 1980). Neonatal argininosuccinic aciduria-survival after early diagnosis and dietary management. J Pediatr, 96, 429-31. doi:10.1016/s0022-3476(80)80688-3 |
| F.5469 |
Cordero, D.R., Baker, J., Dorinzi, D., & Toffle, R. (2005). Ornithine transcarbamylase deficiency in pregnancy. J Inherit Metab Dis, 28, 237-40. doi:10.1007/s10545-005-5514-4 |
| F.5513 |
Crosbie, D.C., Sugumar, H., Simpson, M.A., Walker, S.P., Dewey, H.M., & Reade, M.C. (Sep 2009). Late-onset ornithine transcarbamylase deficiency: a potentially fatal yet treatable cause of coma. Crit Care Resusc, 11(3):222-7. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19737127 |
| F.5512 |
Cui, X., Jauregui, R., Park, K.S., & Tsang, S.H. (Aug 2018). Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy. Ophthalmic Genet, 39, 512-516. doi:10.1080/13816810.2018.1474370 |
| F.5509 |
Daijo, K., Kawaoka, T., Nakahara, T., Nagaoki, Y., Tsuge, M., Hiramatsu, A., Imamura, M., Kawakami, Y., Aikata, H., Hara, K., Tajima, G., Kobayashi, M., & Chayama, K. (Aug 2017). Late-onset ornithine transcarbamylase deficiency associated with hyperammonemia. Clin J Gastroenterol, 10, 383-387. doi:10.1007/s12328-017-0753-0 |
| F.5037 |
Debray, F.G., Lambert, M., Lemieux, B., Soucy, J.F., Drouin, R., Fenyves, D., Dubé, J., Maranda, B., Laframboise, R., & Mitchell, G.A. (Nov 2008). Phenotypic variability among patients with hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15. J Med Genet, 45, 759-64. doi:10.1136/jmg.2008.059097 |
| F.5147 |
Di Rocco, M., Buoncompagni, A., Gattorno, M., Picco, P., Vignola, S., & Borrone, C. (Aug 1998). Complications of lysinuric protein intolerance must be treated with immunosuppressive drugs. J Inherit Metab Dis, 21, 675-6. doi:10.1023/a:1005440802688 |
| F.5151 |
Diaz, G.A., Krivitzky, L.S., Mokhtarani, M., Rhead, W., Bartley, J., Feigenbaum, A., Longo, N., Berquist, W., Berry, S.A., Gallagher, R., Lichter-Konecki, U., Bartholomew, D., Harding, C.O., Cederbaum, S., McCandless, S.E., Smith, W., Vockley, G., Bart, S.A., Korson, M.S., Kronn, D., Zori, R., Merritt, J.L., C S Nagamani, S., Mauney, J., Lemons, C., Dickinson, K., Moors, T.L., Coakley, D.F., Scharschmidt, B.F., & Lee, B. (Jun 2013). Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate. Hepatology, 57, 2171-9. doi:10.1002/hep.26058 |
| F.5150 |
Diaz, G.A., Schulze, A., Longo, N., Rhead, W., Feigenbaum, A., Wong, D., Merritt, J.L., Berquist, W., Gallagher, R.C., Bartholomew, D., McCandless, S.E., Smith, W.E., Harding, C.O., Zori, R., Lichter-Konecki, U., Vockley, J., Canavan, C., Vescio, T., Holt, R.J., & Berry, S.A. (Aug 2019). Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients. Mol Genet Metab, 127, 336-345. doi:10.1016/j.ymgme.2019.07.004 |
| F.5060 |
Diez-Fernandez, C., Rüfenacht, V., Santra, S., Lund, A.M., Santer, R., Lindner, M., Tangeraas, T., Unsinn, C., de Lonlay, P., Burlina, A., van Karnebeek, C.D., & Häberle, J. (Oct 2016). Defective hepatic bicarbonate production due to carbonic anhydrase VA deficiency leads to early-onset life-threatening metabolic crisis. Genet Med, 18, 991-1000. doi:10.1038/gim.2015.201 |
| F.5065 |
Dolman, C.L., Clasen, R.A., & Dorovini-Zis, K. (1988). Severe cerebral damage in ornithine transcarbamylase deficiency. Clin Neuropathol, 7(1):10-5. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3370859 |
| F.4535 |
Dorum, S., & Havalı, C. (Jan 2022). Case series of arginase 1 deficiency: Expanding the spectrum in hyperargininemia. Pediatr Int, 64, e14945. doi:10.1111/ped.14945 |
| F.4543 |
Drogari, E., & Leonard, J.V. (Nov 1988). Late onset ornithine carbamoyl transferase deficiency in males. Arch Dis Child, 63, 1363-7. doi:10.1136/adc.63.11.1363 |
| F.5414 |
Drury, I., Mellinger, J.F., & Michels, V.V. (Jun 1986). Episodic Tourette's syndrome in a patient with citrullinemia. Ann Neurol, 19, 612. doi:10.1002/ana.410190625 |
| F.4551 |
Dutoit, A.P., Flick, R.R., Sprung, J., Babovic-Vuksanovic, D., & Weingarten, T.N. (Jul 2010). Anesthetic implications of ornithine transcarbamylase deficiency. Paediatr Anaesth, 20, 666-73. doi:10.1111/j.1460-9592.2010.03322.x |
| F.4553 |
Eather, G., Coman, D., Lander, C., & McGill, J. (Jul 2006). Carbamyl phosphate synthase deficiency: diagnosed during pregnancy in a 41-year-old. J Clin Neurosci, 13, 702-6. doi:10.1016/j.jocn.2005.07.014 |
| F.5416 |
Ediger, K., Hicks, A., Siriwardena, K., & Joynt, C. (Mar 2021). Brain-lung-thyroid syndrome in a neonate with argininosuccinate lyase deficiency. BMJ Case Rep, 14, . doi:10.1136/bcr-2020-241032 |
| F.4556 |
Edwards, R.L., Moseley, K., Watanabe, Y., Wong, L.J., Ottina, J., & Yano, S. (Dec 2009). Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with argininaemia diagnosed by newborn screening. J Inherit Metab Dis, 32 Suppl 1, S197-200. doi:10.1007/s10545-009-1148-2 |
| F.4565 |
Elpeleg, N., & Korman, S.H. (Jun 2001). Sustained oral lysine supplementation in ornithine delta-aminotransferase deficiency. J Inherit Metab Dis, 24, 423-4. doi:10.1023/a:1010545811361 |
| F.4566 |
Elpeleg, O.N., Colombo, J.P., Amir, N., Bachmann, C., & Hurvitz, H. (Jun 1990). Late-onset form of partial N-acetylglutamate synthetase deficiency. Eur J Pediatr, 149, 634-6. doi:10.1007/BF02034751 |
| F.4567 |
Eminoğlu, F.T., Öncül, Ü., Kahveci, F., Okulu, E., Kraja, E., Köse, E., & Kendirli, T. (Jun 2022). Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders. Pediatr Nephrol, 37, 1387-1397. doi:10.1007/s00467-021-05329-9 |
| F.4577 |
Enns, G.M., & Packman, W. (Jun 2002). The adolescent with an inborn error of metabolism: medical issues and transition to adulthood. Adolesc Med, 13(2):315-29, vii. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11986039 |
| F.5071 |
Enns, G.M., Berry, S.A., Berry, G.T., Rhead, W.J., Brusilow, S.W., & Hamosh, A. (May 2007). Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med, 356, 2282-92. doi:10.1056/NEJMoa066596 |
| F.4578 |
Enns, G.M., O'Brien, W.E., Kobayashi, K., Shinzawa, H., & Pellegrino, J.E. (May 2005). Postpartum "psychosis" in mild argininosuccinate synthetase deficiency. Obstet Gynecol, 105, 1244-6. doi:10.1097/01.AOG.0000157769.90230.24 |
| F.4579 |
Enns, G.M., Porter, M.H., Francis-Sedlak, M., Burdett, A., & Vockley, J. (2019). Perspectives on urea cycle disorder management: Results of a clinician survey. Mol Genet Metab, 128, 102-108. doi:10.1016/j.ymgme.2019.07.009 |
| F.5419 |
Erickson, J., & Schrier Vergano, S.A. (Feb 2019). Case 3: The Hypothermic Newborn. Neoreviews, 20, e93-e95. doi:10.1542/neo.20-2-e93 |
| F.5420 |
Esposito, V., Lettiero, T., Fecarotta, S., Sebastio, G., Parenti, G., & Salerno, M. (Nov 2006). Growth hormone deficiency in a patient with lysinuric protein intolerance. Eur J Pediatr, 165, 763-6. doi:10.1007/s00431-006-0170-8 |
| F.7970 |
Evans, M., Truby, H., & Boneh, A. (Sep 2017). The Relationship between Dietary Intake, Growth, and Body Composition in Inborn Errors of Intermediary Protein Metabolism. J Pediatr, 188, 163-172. doi:10.1016/j.jpeds.2017.05.048 |
| F.5137 |
Faghfoury, H., Baruteau, J., de Baulny, H.O., Häberle, J., & Schulze, A. (Apr 2011). Transient fulminant liver failure as an initial presentation in citrullinemia type I. Mol Genet Metab, 102, 413-7. doi:10.1016/j.ymgme.2010.12.007 |
| F.5118 |
Fantur, M., Karall, D., Scholl-Buergi, S., Häberle, J., Rauchenzauner, M., & Fruehwirth, M. (Jan 2013). Recurrent somnolence in a 17-month-old infant: late-onset ornithine transcarbamylase (OTC) deficiency due to the novel hemizygous mutation c.535C > T (p.Leu179Phe). Eur J Paediatr Neurol, 17, 112-5. doi:10.1016/j.ejpn.2012.05.007 |
| F.5087 |
Fassier, T., Guffon, N., Acquaviva, C., D'Amato, T., Durand, D.V., & Domenech, P. (Jun 2011). Misdiagnosed postpartum psychosis revealing a late-onset urea cycle disorder. Am J Psychiatry, 168, 576-80. doi:10.1176/appi.ajp.2010.10071032 |
| F.5136 |
Feldman, R.B., Mayo, S.S., Robertson, D.M., Jones, J.D., & Rostvold, J.A. (1989). Epiretinal membranes and cystoid macular edema in gyrate atrophy of the choroid and retina. Retina, 9, 139-42. doi:10.1097/00006982-198909020-00014 |
| F.5422 |
Fessatou, S., Garoufi, A., Tsapra, H., Maropoulos, G., Michelakakis, H., & Schulpis, K. (2003). Late onset ornithine transcarbamylase deficiency: a case report. Pediatr Pathol Mol Med, 22, 153-7. doi:10.1080/pdp.22.2.153.157 |
| F.5126 |
Ficicioglu, C., Mandell, R., & Shih, V.E. (Nov 2009). Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening. Mol Genet Metab, 98, 273-7. doi:10.1016/j.ymgme.2009.06.011 |
| F.5423 |
Field, T.O., Dominic, W.J., & Hansbrough, J.F. (Jun 1987). An inherited enzyme deficiency resulting in hyperammonaemia and coma in a burn patient. Burns Incl Therm Inj, 13, 229-31. doi:10.1016/0305-4179(87)90171-9 |
| F.5106 |
Fiermonte, G., Parisi, G., Martinelli, D., De Leonardis, F., Torre, G., Pierri, C.L., Saccari, A., Lasorsa, F.M., Vozza, A., Palmieri, F., & Dionisi-Vici, C. (Dec 2011). A new Caucasian case of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD): a clinical, molecular, and functional study. Mol Genet Metab, 104, 501-6. doi:10.1016/j.ymgme.2011.08.022 |
| F.5109 |
Fletcher, J.M., Couper, R., Moore, D., Coxon, R., & Dorney, S. (Jun 1999). Liver transplantation for citrullinaemia improves intellectual function. J Inherit Metab Dis, 22, 581-6. doi:10.1023/a:1005561509704 |
| F.5007 |
Foschi, F.G., Morelli, M.C., Savini, S., Dall'Aglio, A.C., Lanzi, A., Cescon, M., Ercolani, G., Cucchetti, A., Pinna, A.D., & Stefanini, G.F. (Apr 2015). Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review. World J Gastroenterol, 21, 4063-8. doi:10.3748/wjg.v21.i13.4063 |
| F.5006 |
Foster, R.S., & Halbert, A.R. (2011). What is your diagnosis? An 18-month-old child with ornithine transcarbamylase deficiency and a rash. Pediatr Dermatol, 28, 457-8. doi:10.1111/j.1525-1470.2011.01503.x |
| F.4996 |
Fründ, S., Kuwertz-Bröking, E., Koch, H.G., Bulla, M., & Harms, E. (Jul 1996). The addition of aminoacids and phosphate to hemodiafiltration solutions in newborns with hyperammonemic coma. Clin Nephrol, 46(1):64-6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8832155 |
| F.4988 |
Fu, C.L., Hu, Y.F., & Song, Y.Z. (Sep 2016). Idiopathic eruptive macular pigmentation in a child with citrin deficiency. Pediatr Int, 58, 902-5. doi:10.1111/ped.13007 |
| F.4978 |
Fukushima, K., Yazaki, M., Nakamura, M., Tanaka, N., Kobayashi, K., Saheki, T., Takei, H., & Ikeda, S. (2010). Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency. Intern Med, 49, 243-7. doi:10.2169/internalmedicine.49.2712 |
| F.4975 |
Funghini, S., Thusberg, J., Spada, M., Gasperini, S., Parini, R., Ventura, L., Meli, C., De Cosmo, L., Sibilio, M., Mooney, S.D., Guerrini, R., Donati, M.A., & Morrone, A. (Feb 2012). Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohort. Gene, 493, 228-34. doi:10.1016/j.gene.2011.11.052 |
| F.4968 |
Gallagher, A.C., Pike, M., & Standing, S. (Jun 2001). HHH syndrome associated with callosal agenesis and disordered neuronal migration. Dev Med Child Neurol, 43(6):430-1. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11409836 |
| F.0 |
Metoki, K., Hommes, F.A., Dyken, P., Kelloes, C., & Trefz, J. (1984). Ultrastructural changes in fibroblast mitochondria of a patient with HHH-syndrome. J Inherit Metab Dis, 7, 147-50. doi:10.1007/BF01805595 |
| F.4952 |
Gardeitchik, T., Humphrey, M., Nation, J., & Boneh, A. (Aug 2012). Early clinical manifestations and eating patterns in patients with urea cycle disorders. J Pediatr, 161, 328-32. doi:10.1016/j.jpeds.2012.02.006 |
| F.4948 |
Gaspari, R., Arcangeli, A., Mensi, S., Wismayer, D.S., Tartaglione, T., Antuzzi, D., Conti, G., & Proietti, R. (Jan 2003). Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma. Ann Emerg Med, 41, 104-9. doi:10.1067/mem.2003.6 |
| F.4942 |
Gömez, L., García-Cazorla, A., Gutiérrez, A., Artuch, R., Varea, V., Martín, J., Pinillos, S., & Vilaseca, M.A. (Oct 2006). Treatment of severe osteoporosis with alendronate in a patient with lysinuric protein intolerance. J Inherit Metab Dis, 29, 687. doi:10.1007/s10545-006-0236-9 |
| F.4935 |
Güzel-Ozantürk, A., Ozgül, R.K., Unal, O., Hişmi, B., Aydın, H.İ., Sivri, S., Tokatlı, A., Coşkun, T., Aksöz, E., & Dursun, A. (Jun 2013). Molecular and clinical evaluation of Turkish patients with lysinuric protein intolerance. Gene, 521, 293-5. doi:10.1016/j.gene.2013.03.033 |
| F.4923 |
Gessler, P., Buchal, P., Schwenk, H.U., & Wermuth, B. (Feb 2010). Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency. Eur J Pediatr, 169, 197-9. doi:10.1007/s00431-009-1006-0 |
| F.4905 |
Gjessing, L.R., Lunde, H.A., Undrum, T., Broch, H., Alme, A., & Lie, S.O. (1986). A new patient with hyperornithinaemia, hyperammonaemia and homocitrullinuria treated early with low protein diet. J Inherit Metab Dis, 9, 186-92. doi:10.1007/BF01799457 |
| F.4883 |
Gordon, B.A., Gatfield, D.P., & Haust, M.D. (Jul 1987). The hyperornithinemia, hyperammonemia, homocitrullinuria syndrome: an ornithine transport defect remediable with ornithine supplements. Clin Invest Med, 10(4):329-36. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3652557 |
| F.4876 |
Goto, I., Yoshimura, T., & Kuroiwa, Y. (Feb 1984). Growth hormone studies in lysinuric protein intolerance. Eur J Pediatr, 141, 240-2. doi:10.1007/BF00572769 |
| F.4861 |
Grimaud, M., de Lonlay, P., Dupic, L., Arnoux, J.B., Brassier, A., Hubert, P., Lesage, F., & Oualha, M. (Jun 2016). High glucose intake and glycaemic level in critically ill neonates with inherited metabolic disorders of intoxication. Eur J Pediatr, 175, 849-58. doi:10.1007/s00431-016-2717-7 |
| F.4858 |
Grioni, D., Furlan, F., Corbetta, C., Barboni, C., Lastrico, A., Marzocchi, G.M., Contri, M., Gamba, A., Vizziello, P., & Parini, R. (Jun 2011). Epilepsy and argininosuccinic aciduria. Neuropediatrics, 42, 97-103. doi:10.1055/s-0031-1280795 |
| F.4855 |
Grody, W.W., Chang, R.J., Panagiotis, N.M., Matz, D., & Cederbaum, S.D. (1994). Menstrual cycle and gonadal steroid effects on symptomatic hyperammonaemia of urea-cycle-based and idiopathic aetiologies. J Inherit Metab Dis, 17, 566-74. doi:10.1007/BF00711592 |
| F.4846 |
Gropman, A.L., Prust, M., Breeden, A., Fricke, S., & VanMeter, J. (Jun 2013). Urea cycle defects and hyperammonemia: effects on functional imaging. Metab Brain Dis, 28, 269-75. doi:10.1007/s11011-012-9348-0 |
| F.4826 |
Gugelmo, G., Lenzini, L., Francini-Pesenti, F., Fasan, I., Spinella, P., Valentini, R., Miraval, A., Avogaro, A., & Vitturi, N. (Jan 2022). Anthropometrics, Dietary Intake and Body Composition in Urea Cycle Disorders and Branched Chain Organic Acidemias: A Case Study of 18 Adults on Low-Protein Diets. Nutrients, 14, . doi:10.3390/nu14030467 |
| F.4824 |
Guibaud, P., Baxter, P., Bourgeois, J., Louis, J.J., & Bureau, J. (May 1984). Severe ornithine transcarbamylase deficiency. Two and a half years' survival with normal development. Arch Dis Child, 59, 477-9. doi:10.1136/adc.59.5.477 |
| F.4822 |
Gulati, S., Menon, S., Kabra, M., & Kalra, V. (Jul 2004). Intermittent hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency. Indian J Pediatr, 71, 645-7. doi:10.1007/BF02724127 |
| F.4816 |
Gupta, N., & Kabra, M. (Jul 2011). Acute management of sick infants with suspected inborn errors of metabolism. Indian J Pediatr, 78, 854-9. doi:10.1007/s12098-011-0422-0 |
| F.4811 |
Gyato, K., Wray, J., Huang, Z.J., Yudkoff, M., & Batshaw, M.L. (Jan 2004). Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann Neurol, 55, 80-6. doi:10.1002/ana.10794 |
| F.6016 |
Hasegawa, T., Tzakis, A.G., Todo, S., Reyes, J., Nour, B., Finegold, D.N., & Starzl, T.E. (Jun 1995). Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J Pediatr Surg, 30, 863-5. doi:10.1016/0022-3468(95)90766-1 |
| F.6516 |
Hayasaka, K., Numakura, C., Yamakawa, M., Mitsui, T., Watanabe, H., Haga, H., Yazaki, M., Ohira, H., Ochiai, Y., Tahara, T., Nakahara, T., Yamashiki, N., Nakayama, T., Kon, T., Mitsubuchi, H., & Yoshida, H. (Sep 2018). Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia. J Inherit Metab Dis, 41, 777-784. doi:10.1007/s10545-018-0176-1 |
| F.6517 |
Hayasaka, S., Saito, T., Nakajima, H., Takahashi, O., Mizuno, K., & Tada, K. (Apr 1985). Clinical trials of vitamin B6 and proline supplementation for gyrate atrophy of the choroid and retina. Br J Ophthalmol, 69, 283-90. doi:10.1136/bjo.69.4.283 |
| F.6518 |
Hayasaka, S., Saito, T., Nakajima, H., Takaku, Y., Shiono, T., Mizuno, K., Ohmura, K., & Tada, K. (Jul 1981). Gyrate atrophy with hyperornithinaemia: different types of responsiveness to vitamin B6. Br J Ophthalmol, 65, 478-83. doi:10.1136/bjo.65.7.478 |
| F.7966 |
Häberle, J. (2011). Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency. Ther Clin Risk Manag, 7, 327-32. doi:10.2147/TCRM.S12703 |
| F.6373 |
Häberle, J., Boddaert, N., Burlina, A., Chakrapani, A., Dixon, M., Huemer, M., Karall, D., Martinelli, D., Crespo, P.S., Santer, R., Servais, A., Valayannopoulos, V., Lindner, M., Rubio, V., & Dionisi-Vici, C. (May 2012). Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis, 7, 32. doi:10.1186/1750-1172-7-32 |
| F.7963 |
Häberle, J., Burlina, A., Chakrapani, A., Dixon, M., Karall, D., Lindner, M., Mandel, H., Martinelli, D., Pintos-Morell, G., Santer, R., Skouma, A., Servais, A., Tal, G., Rubio, V., Huemer, M., & Dionisi-Vici, C. (Nov 2019). Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis, 42, 1192-1230. doi:10.1002/jimd.12100 |
| F.6528 |
Häberle, J., Vilaseca, M.A., Meli, C., Rigoldi, M., Jara, F., Vecchio, I., Capra, C., & Parini, R. (Apr 2010). First manifestation of citrullinemia type I as differential diagnosis to postpartum psychosis in the puerperal period. Eur J Obstet Gynecol Reprod Biol, 149, 228-9. doi:10.1016/j.ejogrb.2009.11.014 |
| F.7311 |
Heinänen, K., Näntö-Salonen, K., Komu, M., Erkintalo, M., Alanen, A., Heinonen, O.J., Pulkki, K., Nikoskelainen, E., Sipilä, I., & Simell, O. (Dec 1999). Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia. Eur J Clin Invest, 29, 1060-5. doi:10.1046/j.1365-2362.1999.00569.x |
| G.187 |
Heisler B, Lynn H, Kopesky (Balliet) J, Dimmock D (2020). Standards of Practice Urea Cycle Disorders. Children's Hospital of Wisconsin, Milwaukee, WI |
| F.6521 |
Heller, D., Weiner, C., Nasie, I., Anikster, Y., Landau, Y., Koren, T., Pokroy, R., Abulafia, A., & Pras, E. (Dec 2017). Reversal of cystoid macular edema in gyrate atrophy patients. Ophthalmic Genet, 38, 549-554. doi:10.1080/13816810.2017.1301966 |
| F.7313 |
Heringlake, S., Böker, K., & Manns, M. (1997). Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient. Digestion, 58, 83-6. doi:10.1159/000201428 |
| F.7317 |
Hinnie, J., Colombo, J.P., Wermuth, B., & Dryburgh, F.J. (Nov 1997). N-Acetylglutamate synthetase deficiency responding to carbamylglutamate. J Inherit Metab Dis, 20, 839-40. doi:10.1023/a:1005344507536 |
| F.7318 |
Hirai, I., Kimura, W., Suto, K., Fzjimoto, H., Watanabe, T., Fuse, A., Kobayashi, K., Iijima, M., Saheki, T., Nakatsuka, T., Sugawara, Y., & Makuuchi, M. (2008). Living donor liver transplantation for type II citrullinemia from a heterozygous donor. Hepatogastroenterology, 55(88):2211-6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19260507 |
| F.7320 |
Hommes, F.A., Roesel, R.A., Metoki, K., Hartlage, P.L., & Dyken, P.R. (Feb 1986). Studies on a case of HHH-syndrome (hyperammonemia, hyperornithinemia, homocitrullinuria). Neuropediatrics, 17, 48-52. doi:10.1055/s-2008-1052499 |
| F.7326 |
Hoogenraad, N.J., Mitchell, J.D., Don, N.A., Sutherland, T.M., & Mc Leay, A.C. (Apr 1980). Detection of carbamyl phosphate synthetase 1 deficiency using duodenal biopsy samples. Arch Dis Child, 55, 292-5. doi:10.1136/adc.55.4.292 |
| F.7972 |
Hook, D., Diaz, G.A., Lee, B., Bartley, J., Longo, N., Berquist, W., Le Mons, C., Rudolph-Angelich, I., Porter, M., Scharschmidt, B.F., & Mokhtarani, M. (Mar 2016). Protein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate. Mol Genet Metab Rep, 6, 34-40. doi:10.1016/j.ymgmr.2015.11.002 |
| F.7331 |
Hoshino, Y., Kodaira, M., Matsuno, A., Kaneko, T., Fukuyama, T., Takano, K., Yazaki, M., & Sekijima, Y. (Feb 2022). Reversible Leukoencephalopathy in a Man with Childhood-onset Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome. Intern Med, 61, 553-557. doi:10.2169/internalmedicine.7843-21 |
| F.7332 |
Houston, B., Reiss, K.A., & Merlo, C. (Apr 2011). Healthy, but comatose. Am J Med, 124, 303-5. doi:10.1016/j.amjmed.2010.12.002 |
| F.7334 |
Hu, S.W., Lu, W.L., Chiang, I.P., Wu, S.F., Wang, C.H., & Chen, A.C. (Sep 2021). Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency with Mutation Presenting Hepatic Steatosis and Prolonged Jaundice. A Rare Case Report. Medicina (Kaunas), 57, . doi:10.3390/medicina57101032 |
| F.7335 |
Huang, H.P., Chien, Y.H., Huang, L.M., Ni, Y.H., Chang, M.H., Ho, M.C., Lee, P.H., & Hwu, W.L. (Sep 2005). Viral infections and prolonged fever after liver transplantation in young children with inborn errors of metabolism. J Formos Med Assoc, 104(9):623-9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16276436 |
| F.7342 |
Huemer, M., Carvalho, D.R., Brum, J.M., Ünal, Ö., Coskun, T., Weisfeld-Adams, J.D., Schrager, N.L., Scholl-Bürgi, S., Schlune, A., Donner, M.G., Hersberger, M., Gemperle, C., Riesner, B., Ulmer, H., Häberle, J., & Karall, D. (May 2016). Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency. J Inherit Metab Dis, 39, 331-340. doi:10.1007/s10545-016-9928-y |
| F.6553 |
Huner, G., Baykal, T., Demir, F., & Demirkol, M. (2005). Breastfeeding experience in inborn errors of metabolism other than phenylketonuria. J Inherit Metab Dis, 28, 457-65. doi:10.1007/s10545-005-0457-3 |
| F.7344 |
Hutchin, T., Preece, M.A., Hendriksz, C., Chakrapani, A., McClelland, V., Okumura, F., Song, Y.Z., Iijima, M., Kobayashi, K., Saheki, T., McKiernan, P., & Baumann, U. (Dec 2009). Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) as a cause of liver disease in infants in the UK. J Inherit Metab Dis, 32 Suppl 1, S151-5. doi:10.1007/s10545-009-1116-x |
| F.7345 |
Hwu, W.L., Chien, Y.H., Tang, N.L., Law, L.K., Lin, C.Y., & Lee, N.C. (Oct 2007). Deficiency of the carnitine transporter (OCTN2) with partial N-acetylglutamate synthase (NAGS) deficiency. J Inherit Metab Dis, 30, 816. doi:10.1007/s10545-007-0594-y |
| F.6564 |
Hyman, S.L., Porter, C.A., Page, T.J., Iwata, B.A., Kissel, R., & Batshaw, M.L. (Oct 1987). Behavior management of feeding disturbances in urea cycle and organic acid disorders. J Pediatr, 111, 558-62. doi:10.1016/s0022-3476(87)80121-x |
| F.6568 |
Ikeri, K., Cardona, V.Q., Hagan-Brown, A., Young, M., Schneider, M., & Menkiti, O. (Mar 2020). ECMO as a Platform for Rapid Ammonia Removal in a Neonate with Multienzyme Urea Cycle Disorder. J Extra Corpor Technol, 52, 58-62. doi:10.1182/JECT-1900032 |
| F.7408 |
Ishida, T., Hiroma, T., Hashikura, Y., Horiuchi, M., Kobayashi, K., & Nakamura, T. (Jun 2009). Early neonatal onset carbamoyl-phosphate synthase 1 deficiency treated with continuous hemodiafiltration and early living-related liver transplantation. Pediatr Int, 51, 409-10. doi:10.1111/j.1442-200X.2009.02831.x |
| F.7362 |
Ituk, U., Constantinescu, O.C., Allen, T.K., Small, M.J., & Habib, A.S. (Jan 2012). Peripartum management of two parturients with ornithine transcarbamylase deficiency. Int J Obstet Anesth, 21, 90-3. doi:10.1016/j.ijoa.2011.09.007 |
| F.7416 |
Iyer, H., Sen, M., Prasad, C., Rupar, C.A., & Lindsay, R.M. (Jan 2012). Coma, hyperammonemia, metabolic acidosis, and mutation: lessons learned in the acute management of late onset urea cycle disorders. Hemodial Int, 16, 95-100. doi:10.1111/j.1542-4758.2011.00591.x |
| F.7431 |
Janwadkar, A., Shirole, N., Nagral, A., Bakshi, R., Vasanth, S., Bagde, A., Yewale, V., & Mirza, D. (Jul 2019). Citrullinemia Type 1: Behavioral Improvement with Late Liver Transplantation. Indian J Pediatr, 86, 639-641. doi:10.1007/s12098-019-02905-8 |
| F.7444 |
John, E.G., Bhat, R., & Bidyasagar, D. (Nov 1980). Neonatal survival after early diagnosis and treatment of argininosuccinic aciduria. J Pediatr, 97, 867-8. doi:10.1016/s0022-3476(80)80292-7 |
| F.7451 |
Kaibori, M., Egawa, H., Inomata, Y., Uemoto, S., Asonuma, K., Kiuchi, T., Varela-Fascinetto, G., Matsukura, T., Kasahara, M., Uryuhara, K., Inui, A., Komatsu, H., Fujisawa, T., & Tanaka, K. (Nov 1998). Strategy used to overcome graft atrophy in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency. Transplant Proc, 30, 3221-2. doi:10.1016/s0041-1345(98)01003-3 |
| F.7450 |
Kaibori, M., Egawa, H., Inomata, Y., Uemoto, S., Asonuma, K., Kiuchi, T., Varela-Fascinetto, G., Matsukura, T., Kasahara, M., Uryuhara, K., Inui, A., Komatsu, H., Fujisawa, T., & Tanaka, K. (Oct 1998). Selective portal blood flow diversion in auxiliary partial orthotopic liver transplantation to induce regeneration of the graft. Transplantation, 66, 935-7. doi:10.1097/00007890-199810150-00022 |
| F.7452 |
Kaiser-Kupfer, M.I., Caruso, R.C., & Valle, D. (Nov 1991). Gyrate atrophy of the choroid and retina. Long-term reduction of ornithine slows retinal degeneration. Arch Ophthalmol, 109, 1539-48. doi:10.1001/archopht.1991.01080110075039 |
| F.7454 |
Kaiser-Kupfer, M.I., Caruso, R.C., Valle, D., & Reed, G.F. (Jul 2004). Use of an arginine-restricted diet to slow progression of visual loss in patients with gyrate atrophy. Arch Ophthalmol, 122, 982-4. doi:10.1001/archopht.122.7.982 |
| F.7456 |
Kaiser-Kupfer, M.I., de Monasterio, F.M., Valle, D., Walser, M., & Brusilow, S. (Dec 1980). Gyrate atrophy of the choroid and retina: improved visual function following reduction of plasma ornithine by diet. Science, 210, 1128-31. doi:10.1126/science.7444439 |
| F.7458 |
Kaiser-Kupfer, M.I., Ludwig, I.H., de Monasterio, F.M., Valle, D., & Krieger, I. (Mar 1985). Gyrate atrophy of the choroid and retina. Early findings. Ophthalmology, 92, 394-401. doi:10.1016/s0161-6420(85)34022-8 |
| F.7459 |
Kaiser-Kupfer, M.I., Valle, D., & Bron, A.J. (Feb 1980). Clinical and biochemical heterogeneity in gyrate atrophy. Am J Ophthalmol, 89, 219-22. doi:10.1016/0002-9394(80)90114-2 |
| F.7244 |
Kasahara, M., Kiuchi, T., Uryuhara, K., Ogura, Y., Takakura, K., Egawa, H., Asonuma, K., Uemoto, S., Inomata, Y., & Tanaka, K. (Dec 1998). Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in a living-donor program. J Pediatr Surg, 33, 1753-6. doi:10.1016/s0022-3468(98)90278-0 |
| F.7243 |
Kasahara, M., Ohwada, S., Takeichi, T., Kaneko, H., Tomomasa, T., Morikawa, A., Yonemura, K., Asonuma, K., Tanaka, K., Kobayashi, K., Saheki, T., Takeyoshi, I., & Morishita, Y. (Jan 2001). Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. Transplantation, 71, 157-9. doi:10.1097/00007890-200101150-00027 |
| F.7240 |
Kasahara, M., Sakamoto, S., Shigeta, T., Fukuda, A., Kosaki, R., Nakazawa, A., Uemoto, S., Noda, M., Naiki, Y., & Horikawa, R. (Dec 2010). Living-donor liver transplantation for carbamoyl phosphate synthetase 1 deficiency. Pediatr Transplant, 14, 1036-40. doi:10.1111/j.1399-3046.2010.01402.x |
| F.7239 |
Kasahara, M., Takada, Y., Kozaki, K., Uryuhara, K., Ogura, Y., Ogawa, K., Fujimoto, Y., & Tanaka, K. (Jul 2004). Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease. J Pediatr Surg, 39, 1138-41. doi:10.1016/j.jpedsurg.2004.03.079 |
| F.7237 |
Katagiri, S., Gekka, T., Hayashi, T., Ida, H., Ohashi, T., Eto, Y., & Tsuneoka, H. (Apr 2014). OAT mutations and clinical features in two Japanese brothers with gyrate atrophy of the choroid and retina. Doc Ophthalmol, 128, 137-48. doi:10.1007/s10633-014-9426-1 |
| F.7226 |
Kawagishi, N., Satoh, K., Enomoto, Y., Akamatsu, Y., Sekiguchi, S., Satoh, A., Fujimori, K., Takasago, Y., Ito, T., Ohura, T., & Satomi, S. (2005). Improved quality of life and unchanged magnetic resonance brain imaging after living donor liver transplantation for late-onset ornithine transcarbamylase deficiency: report of a case. Surg Today, 35, 1087-91. doi:10.1007/s00595-005-3071-y |
| F.7220 |
Kawata, A., Suda, M., & Tanabe, H. (Jun 1997). Adult-onset type II citrullinemia: clinical pictures before and after liver transplantation. Intern Med, 36, 408-12. doi:10.2169/internalmedicine.36.408 |
| F.7216 |
Kayanoki, Y., Kawata, S., Yamasaki, E., Kiso, S., Inoue, S., Tamura, S., Taniguchi, N., & Matsuzawa, Y. (Sep 1999). Reduced nitric oxide production by L-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation. Metabolism, 48, 1136-40. doi:10.1016/s0026-0495(99)90127-0 |
| F.7210 |
Köse, M.D., Kagnici, M., Özdemir, T.R., Erdur, C.B., Erdemir, G., Karakoyun, M., Guzin, Y., Ceylaner, S., & Genel, F. (Jan 2020). Clinical findings in five Turkish patients with citrin deficiency and identification of a novel mutation on SLC25A13. J Pediatr Endocrinol Metab, 33, 157-163. doi:10.1515/jpem-2019-0377 |
| F.7198 |
Kennaway, N.G., Weleber, R.G., & Buist, N.R. (Jul 1980). Gyrate atrophy of the choroid and retina with hyperornithinemia: biochemical and histologic studies and response to vitamin B6. Am J Hum Genet, 32(4):529-41. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7395865 |
| F.7183 |
Kibleur, Y., & Guffon, N. (Apr 2016). Long-Term Follow-Up on a Cohort Temporary Utilization Authorization (ATU) Survey of Patients Treated with Pheburane (Sodium Phenylbutyrate) Taste-Masked Granules. Paediatr Drugs, 18, 139-44. doi:10.1007/s40272-015-0159-8 |
| F.7180 |
Kido, J., Matsumoto, S., Häberle, J., Inomata, Y., Kasahara, M., Sakamoto, S., Horikawa, R., Tanemura, A., Okajima, H., Suzuki, T., & Nakamura, K. (Nov 2021). Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan. J Inherit Metab Dis, 44, 1311-1322. doi:10.1002/jimd.12415 |
| F.7179 |
Kido, J., Matsumoto, S., Häberle, J., Nakajima, Y., Wada, Y., Mochizuki, N., Murayama, K., Lee, T., Mochizuki, H., Watanabe, Y., Horikawa, R., Kasahara, M., & Nakamura, K. (Jul 2021). Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan. J Inherit Metab Dis, 44, 826-837. doi:10.1002/jimd.12384 |
| F.7178 |
Kido, J., Matsumoto, S., Mitsubuchi, H., Endo, F., & Nakamura, K. (Oct 2018). Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment. Metab Brain Dis, 33, 1517-1523. doi:10.1007/s11011-018-0259-6 |
| F.7177 |
Kido, J., Matsumoto, S., Momosaki, K., Sakamoto, R., Mitsubuchi, H., Endo, F., & Nakamura, K. (Sep 2017). Liver transplantation may prevent neurodevelopmental deterioration in high-risk patients with urea cycle disorders. Pediatr Transplant, 21, . doi:10.1111/petr.12987 |
| F.7174 |
Kido, J., Yoshida, T., Mitsubuchi, H., Matsumoto, S., & Nakamura, K. (Nov 2017). Impact of the 2016 Kumamoto Earthquake on a female patient with ornithine transcarbamoylase deficiency. Pediatr Int, 59, 1213-1215. doi:10.1111/ped.13419 |
| F.7170 |
Kim, D., Ko, J.M., Kim, Y.M., Seo, G.H., Kim, G.H., Lee, B.H., & Yoo, H.W. (Jul 2018). Low prevalence of argininosuccinate lyase deficiency among inherited urea cycle disorders in Korea. J Hum Genet, 63, 911-917. doi:10.1038/s10038-018-0467-2 |
| F.7168 |
Kim, I.K., Niemi, A.K., Krueger, C., Bonham, C.A., Concepcion, W., Cowan, T.M., Enns, G.M., & Esquivel, C.O. (Mar 2013). Liver transplantation for urea cycle disorders in pediatric patients: a single-center experience. Pediatr Transplant, 17, 158-67. doi:10.1111/petr.12041 |
| F.7166 |
Kim, J.H., Kim, Y.M., Lee, B.H., Cho, J.H., Kim, G.H., Choi, J.H., & Yoo, H.W. (Jul 2015). Short-term efficacy of N-carbamylglutamate in a patient with N-acetylglutamate synthase deficiency. J Hum Genet, 60, 395-7. doi:10.1038/jhg.2015.30 |
| F.7161 |
Kim, S.J., Lim, D.H., Kim, J.H., & Kang, S.W. (Oct 2013). Gyrate atrophy of the choroid and retina diagnosed by ornithine-δ-aminotransferase gene analysis: a case report. Korean J Ophthalmol, 27, 388-91. doi:10.3341/kjo.2013.27.5.388 |
| F.7160 |
Kim, S.Z., Song, W.J., Nyhan, W.L., Ficicioglu, C., Mandell, R., & Shih, V.E. (Jul 2012). Long-term follow-up of four patients affected by HHH syndrome. Clin Chim Acta, 413, 1151-5. doi:10.1016/j.cca.2012.03.015 |
| F.7154 |
King, N., Alvizures, R., García, P., Wessel, A., & Rohloff, P. (Aug 2016). Argininemia as a cause of severe chronic stunting in a low-resource developing country setting: a case report. BMC Pediatr, 16, 142. doi:10.1186/s12887-016-0668-9 |
| F.7149 |
Kiykim, E., & Zubarioglu, T. (Sep 2014). Low dose of carglumic acid for treatment of hyperammonemia due to N-acetylglutamate synthase deficiency. Indian Pediatr, 51(9):755-6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25228620 |
| F.7139 |
Kline, J.J., Hug, G., Schubert, W.K., & Berry, H. (May 1981). Arginine deficiency syndrome. Its occurrence in carbamyl phosphate synthetase deficiency. Am J Dis Child, 135(5):437-42. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7234771 |
| F.7111 |
Kodama, H., Samukawa, K., Okada, S., Nose, O., Maki, I., Yamaguchi, M., & Yabuuchi, H. (Aug 1983). Study of ammonia metabolism in a patient with ornithine transcarbamylase deficiency using an 15N tracer. Clin Chim Acta, 132, 267-75. doi:10.1016/0009-8981(83)90005-0 |
| F.7102 |
Konanki, R., Akella, R.R.D., Panigrahy, N., Chirla, D.K., Mohanlal, S., & Lankala, R. (Aug 2020). Mitochondrial carbonic anhydrase VA deficiency in three Indian infants manifesting early metabolic crisis. Brain Dev, 42, 534-538. doi:10.1016/j.braindev.2020.04.007 |
| F.7093 |
Korman, S.H., Raas-Rothschild, A., Elpeleg, O., & Gutman, A. (May 2002). Hypocarnitinemia in lysinuric protein intolerance. Mol Genet Metab, 76, 81-3. doi:10.1016/s1096-7192(02)00019-7 |
| F.7086 |
Kotani, Y., Shiota, M., Umemoto, M., Tsuritani, M., & Hoshiai, H. (Jul 2010). Carbamyl phosphate synthetase deficiency and postpartum hyperammonemia. Am J Obstet Gynecol, 203, e10-1. doi:10.1016/j.ajog.2010.03.032 |
| F.7082 |
Koya, Y., Shibata, M., Senju, M., Honma, Y., Hiura, M., Ishii, M., Matsumoto, S., & Harada, M. (Apr 2019). Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency. Intern Med, 58, 937-942. doi:10.2169/internalmedicine.1851-18 |
| F.7969 |
Kripps, K.A., Baker, P.R., Thomas, J.A., Skillman, H.E., Bernstein, L., Gaughan, S., Burns, C., Coughlin, C.R., McCandless, S.E., Larson, A.A., Kochar, A., Stillman, C.F., Wymore, E.M., Hendricks, E.G., Woontner, M., & Van Hove, J.L.K. (Jul 2021). REVIEW: Practical strategies to maintain anabolism by intravenous nutritional management in children with inborn metabolic diseases. Mol Genet Metab, 133, 231-241. doi:10.1016/j.ymgme.2021.04.007 |
| F.7070 |
Kuchler, G., Rabier, D., Poggi-Travert, F., Meyer-Gast, D., Bardet, J., Drouin, V., Cadoudal, M., & Saudubray, J.M. (1996). Therapeutic use of carbamylglutamate in the case of carbamoyl-phosphate synthetase deficiency. J Inherit Metab Dis, 19, 220-2. doi:10.1007/BF01799434 |
| F.7060 |
Kumar, K., Agarwal, A., Agarwal, A., Dhawan, A., Chandani, N., & Raj, P. (2015). Ocular manifestations in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: a rare association. Retin Cases Brief Rep, 9, 134-7. doi:10.1097/ICB.0000000000000116 |
| F.6956 |
Kurko, J., Tringham, M., Tanner, L., Näntö-Salonen, K., Vähä-Mäkilä, M., Nygren, H., Pöhö, P., Lietzen, N., Mattila, I., Olkku, A., Hyötyläinen, T., Orešič, M., Simell, O., Niinikoski, H., & Mykkänen, J. (Sep 2016). Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI). Metabolism, 65, 1361-75. doi:10.1016/j.metabol.2016.05.012 |
| F.6953 |
Kvedar, J.C., Baden, H.P., Baden, L.A., Shih, V.E., & Kolodny, E.H. (Aug 1991). Dietary management reverses grooving and abnormal polarization of hair shafts in argininosuccinase deficiency. Am J Med Genet, 40, 211-3. doi:10.1002/ajmg.1320400218 |
| F.5581 |
Lamb, S., Aye, C.Y., Murphy, E., & Mackillop, L. (Jan 2013). Multidisciplinary management of ornithine transcarbamylase (OTC) deficiency in pregnancy: essential to prevent hyperammonemic complications. BMJ Case Rep, 2013, . doi:10.1136/bcr-2012-007416 |
| F.5583 |
Lambert, M.A., Marescau, B., Desjardins, M., Laberge, M., Dhondt, J.L., Dallaire, L., De Deyn, P.P., & Qureshi, I.A. (Mar 1991). Hyperargininemia: intellectual and motor improvement related to changes in biochemical data. J Pediatr, 118, 420-4. doi:10.1016/s0022-3476(05)82161-4 |
| F.5588 |
Langendonk, J.G., Roos, J.C., Angus, L., Williams, M., Karstens, F.P., de Klerk, J.B., Maritz, C., Ben-Omran, T., Williamson, C., Lachmann, R.H., & Murphy, E. (May 2012). A series of pregnancies in women with inherited metabolic disease. J Inherit Metab Dis, 35, 419-24. doi:10.1007/s10545-011-9389-2 |
| F.5618 |
Lee, B., Diaz, G.A., Rhead, W., Lichter-Konecki, U., Feigenbaum, A., Berry, S.A., Le Mons, C., Bartley, J., Longo, N., Nagamani, S.C., Berquist, W., Gallagher, R.C., Harding, C.O., McCandless, S.E., Smith, W., Schulze, A., Marino, M., Rowell, R., Coakley, D.F., Mokhtarani, M., & Scharschmidt, B.F. (Jan 2016). Glutamine and hyperammonemic crises in patients with urea cycle disorders. Mol Genet Metab, 117, 27-32. doi:10.1016/j.ymgme.2015.11.005 |
| F.5620 |
Lee, B., Singh, R.H., Rhead, W.J., Sniderman King, L., Smith, W., & Summar, M.L. (Oct 2005). Considerations in the difficult-to-manage urea cycle disorder patient. Crit Care Clin, 21, S19-25. doi:10.1016/j.ccc.2005.05.001 |
| F.5623 |
Lee, B.H., Jin, H.Y., Kim, G.H., Choi, J.H., & Yoo, H.W. (Mar 2011). Argininemia presenting with progressive spastic diplegia. Pediatr Neurol, 44, 218-20. doi:10.1016/j.pediatrneurol.2010.11.003 |
| F.5625 |
Lee, C.H., Ellaway, C., Shun, A., Thomas, G., Nair, P., O'Neill, J., Shakel, N., & Stormon, M.O. (Feb 2018). Split-graft liver transplantation from an adult donor with an unrecognized UCD to a pediatric and adult recipient. Pediatr Transplant, 22, . doi:10.1111/petr.13073 |
| F.5630 |
Lee, J.Y., Chang, S.E., Suh, C.W., Choi, J.H., Sung, K.J., Moon, K.C., & Koh, J.K. (Jun 2002). A case of acrodermatitis enteropathica-like dermatosis caused by ornithine transcarbamylase deficiency. J Am Acad Dermatol, 46, 965-7. doi:10.1067/mjd.2002.120595 |
| F.5639 |
Legido-Quigley, C., Cloarec, O., Parker, D.A., Murphy, G.M., Holmes, E., Lindon, J.C., Nicholson, J.K., Mitry, R.R., Vilca-Melendez, H., Rela, M., Dhawan, A., & Heaton, N. (Dec 2009). First example of hepatocyte transplantation to alleviate ornithine transcarbamylase deficiency, monitored by NMR-based metabonomics. Bioanalysis, 1, 1527-35. doi:10.4155/bio.09.112 |
| F.5641 |
Legras, A., Labarthe, F., Maillot, F., Garrigue, M.A., Kouatchet, A., & Ogier de Baulny, H. (Jan 2002). Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations. Crit Care Med, 30, 241-4. doi:10.1097/00003246-200201000-00035 |
| F.5648 |
Leonard, J.V. (Jan 2001). The nutritional management of urea cycle disorders. J Pediatr, 138, S40-4;discussion S44-5. doi:10.1067/mpd.2001.111835 |
| F.5650 |
Leonard, J.V., & Morris, A.A. (Feb 2002). Urea cycle disorders. Semin Neonatol, 7, 27-35. doi:10.1053/siny.2001.0085 |
| F.5652 |
Leonard, J.V., Ward Platt, M.P., & Morris, A.A. (Mar 2008). Hypothesis: proposals for the management of a neonate at risk of hyperammonaemia due to a urea cycle disorder. Eur J Pediatr, 167, 305-9. doi:10.1007/s00431-007-0486-z |
| F.5655 |
Letarte, J., Qureshi, I.A., Ouellet, R., & Godard, M. (May 1985). Chronic benzoate therapy in a boy with partial ornithine transcarbamylase deficiency. J Pediatr, 106, 794-7. doi:10.1016/s0022-3476(85)80359-0 |
| G.182 |
Levy H, Kritzer A (2020) Acute Illness Protocol: Citrullinemia. New England Consortium of Metabolic Programs Boston MA. https://www.newenglandconsortium.org/argininosuccinic-acid-synthetase-deficiency-citrullinemia-as |
| G.179 |
Levy H, Kritzer A. (2020) Acute Illness Protocol: Argininosuccinc Acid Lyase Deficiency. New England Consortium of Metabolic Programs https://www.newenglandconsortium.org/argininosuccinic-acid-lyase-deficiency-asa |
| F.5682 |
Lin, W.X., Zhang, Z.H., Deng, M., Cai, X.R., & Song, Y.Z. (Sep 2012). Multiple ovarian antral follicles in a preterm infant with neonatal intrahepatic cholestasis caused by citrin deficiency: a clinical, genetic and transcriptional analysis. Gene, 505, 269-75. doi:10.1016/j.gene.2012.06.012 |
| F.5685 |
Lin, Y., Lin, W., Chen, Y., Lin, C., Zheng, Z., Zhuang, J., & Fu, Q. (Oct 2020). Combined primary carnitine deficiency with neonatal intrahepatic cholestasis caused by citrin deficiency in a Chinese newborn. BMC Pediatr, 20, 478. doi:10.1186/s12887-020-02372-7 |
| F.5694 |
Lipiński, P., Jurkiewicz, D., Ciara, E., Płoski, R., Więcek, S., Bogdańska, A., Stradomska, T., Socha, P., Rokicki, D., Tylki-Szymańska, A., & Jankowska, I. (May 2020). Neonatal cholestasis due to citrin deficiency: diagnostic pitfalls. Acta Biochim Pol, 67, 225-228. doi:10.18388/abp.2020_5202 |
| F.5707 |
Liu, Y., Luo, Y., Xia, L., Qiu, B., Zhou, T., Feng, M., Wang, C., Xue, F., Chen, X., Han, L., Zhang, J., & Xia, Q. (Mar 2021). Outcome of Liver Transplantation for Neonatal-onset Citrullinemia Type I. Transplantation, 105, 569-576. doi:10.1097/TP.0000000000003261 |
| F.5708 |
Lo, S.H., Wong, K.S., & Mo, K.L. (Oct 2003). Treatment by haemodialysis in a case of adult-onset (type II) citrullinaemia in a Chinese patient with pulmonary tuberculosis. Nephrol Dial Transplant, 18, 2182-4. doi:10.1093/ndt/gfg306 |
| F.5709 |
Lo, W.D., Sloan, H.R., Sotos, J.F., & Klinger, R.J. (Mar 1993). Late clinical presentation of partial carbamyl phosphate synthetase I deficiency. Am J Dis Child, 147, 267-9. doi:10.1001/archpedi.1993.02160270029012 |
| F.5717 |
Longo, N., Diaz, G.A., Lichter-Konecki, U., Schulze, A., Inbar-Feigenberg, M., Conway, R.L., Bannick, A.A., McCandless, S.E., Zori, R., Hainline, B., Ah Mew, N., Canavan, C., Vescio, T., Kok, T., Porter, M.H., & Berry, S.A. (Jan 2021). Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders. Mol Genet Metab, 132, 19-26. doi:10.1016/j.ymgme.2020.12.002 |
| F.5731 |
Lu, C.T., Shi, Q.P., Li, Z.J., Li, J., & Feng, L. (Jun 2017). Blood glucose and insulin and correlation of SLC25A13 mutations with biochemical changes in NICCD patients. Exp Biol Med (Maywood), 242, 1271-1278. doi:10.1177/1535370217710918 |
| F.5742 |
Lukkarinen, M., Näntö-Salonen, K., Pulkki, K., Aalto, M., & Simell, O. (Jul 2003). Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance. Metabolism, 52, 935-8. doi:10.1016/s0026-0495(03)00089-1 |
| F.5743 |
Lukkarinen, M., Näntö-Salonen, K., Pulkki, K., Mattila, K., & Simell, O. (May 2000). Effect of lysine infusion on urea cycle in lysinuric protein intolerance. Metabolism, 49, 621-5. doi:10.1016/s0026-0495(00)80038-4 |
| F.5749 |
MacDonald, A., Depondt, E., Evans, S., Daly, A., Hendriksz, C., Chakrapani A, A., & Saudubray, J.M. (2006). Breast feeding in IMD. J Inherit Metab Dis, 29, 299-303. doi:10.1007/s10545-006-0332-x |
| F.5750 |
MaCdonald, A., van Rijn, M., Feillet, F., Lund, A.M., Bernstein, L., Bosch, A.M., Gizewska, M., & van Spronsen, F.J. (2012). Adherence issues in inherited metabolic disorders treated by low natural protein diets. Ann Nutr Metab, 61, 289-95. doi:10.1159/000342256 |
| G.193 |
MacLeod, E. Nutrition Management of Urea Cycle Disorders in Bernstein L, Rohr F, van Calcar S, Nutrition Management of Inherited Metabolic Diseases, 2nd ed. Springer, New York, 2022. pp 225-240. |
| F.5752 |
MacLeod, E.L., Hall, K.D., & McGuire, P.J. (Jan 2016). Computational modeling to predict nitrogen balance during acute metabolic decompensation in patients with urea cycle disorders. J Inherit Metab Dis, 39, 17-24. doi:10.1007/s10545-015-9882-0 |
| F.5757 |
Maestri, N.E., Clissold, D., & Brusilow, S.W. (Mar 1999). Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis. J Pediatr, 134, 268-72. doi:10.1016/s0022-3476(99)70448-8 |
| F.5765 |
Maines, E., Comberiati, P., Piacentini, G.L., Boner, A.L., & Peroni, D.G. (Aug 2013). Lysinuric protein intolerance can be misdiagnosed as food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol, 24, 509-10. doi:10.1111/pai.12096 |
| F.5778 |
Mamourian, A.C., & du Plessis, A. (1991). Urea cycle defect: a case with MR and CT findings resembling infarct. Pediatr Radiol, 21, 594-5. doi:10.1007/BF02012608 |
| F.5785 |
Marble, M., McGoey, R.R., Mannick, E., Keats, B., Ng, S.S., Deputy, S., Gereighty, H., & Schmidt-Sommerfeld, E. (Apr 2008). Living related liver transplant in a patient with argininosuccinic aciduria and cirrhosis: metabolic follow-up. J Pediatr Gastroenterol Nutr, 46, 453-6. doi:10.1097/MPG.0b013e3180ca8720 |
| F.5787 |
Marcus, N., Scheuerman, O., Hoffer, V., Zilbershot-Fink, E., Reiter, J., & Garty, B.Z. (May 2008). Stupor in an adolescent following Yom Kippur fast, due to late-onset ornithine transcarbamylase deficiency. Isr Med Assoc J, 10(5):395-6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18605371 |
| F.5788 |
Mardach, M.R., Roe, K., & Cederbaum, S.D. (Apr 1999). Successful pregnancy outcome in a woman with argininosuccinate lyase deficiency. J Inherit Metab Dis, 22, 102-6. doi:10.1023/a:1005481431955 |
| F.5790 |
Marescau, B., De Deyn, P.P., Lowenthal, A., Qureshi, I.A., Antonozzi, I., Bachmann, C., Cederbaum, S.D., Cerone, R., Chamoles, N., & Colombo, J.P. (Mar 1990). Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy. Pediatr Res, 27, 297-303. doi:10.1203/00006450-199003000-00020 |
| F.5793 |
Marescau, B., Qureshi, I.A., De Deyn, P., Letarte, J., Ryba, R., & Lowenthal, A. (Feb 1985). Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy. Clin Chim Acta, 146, 21-7. doi:10.1016/0009-8981(85)90120-2 |
| F.5794 |
Margalith, D., Crichton, J.U., Wong, L., Davidson, A.G., Applegarth, D.A., & Toone, J.R. (Aug 1983). Argininosuccinic aciduria. A developmental and biochemical case study. J Neurol Sci, 60, 217-33. doi:10.1016/0022-510x(83)90064-3 |
| F.6040 |
Mashima, Y.G., Weleber, R.G., Kennaway, N.G., & Inana, G. (Dec 1999). Genotype-phenotype correlation of a pyridoxine-responsive form of gyrate atrophy. Ophthalmic Genet, 20, 219-24. doi:10.1076/opge.20.4.219.2271 |
| F.6060 |
Matsuda, I., Ohtani, Y., Ohyanagi, K., & Yamamoto, S. (1987). Hyperammonemia related to carnitine metabolism with particular emphasis on ornithine transcarbamylase deficiency. Enzyme, 38, 251-5. doi:10.1159/000469212 |
| F.6061 |
Matsufuji, M., Takeshita, E., Nakashima, M., Watanabe, Y., Fukui, K., Hanai, T., Ishibashi, H., & Takashima, S. (Feb 2020). Sodium phenylbutyrate improved the clinical state in an adult patient with arginase 1 deficiency. Brain Dev, 42, 231-235. doi:10.1016/j.braindev.2019.09.002 |
| F.6074 |
Mauhin, W., Habarou, F., Gobin, S., Servais, A., Brassier, A., Grisel, C., Roda, C., Pinto, G., Moshous, D., Ghalim, F., Krug, P., Deltour, N., Pontoizeau, C., Dubois, S., Assoun, M., Galmiche, L., Bonnefont, J.P., Ottolenghi, C., de Blic, J., Arnoux, J.B., & de Lonlay, P. (Jan 2017). Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood. Orphanet J Rare Dis, 12, 3. doi:10.1186/s13023-016-0550-8 |
| F.6075 |
Mayatepek, E., Kurczynski, T.W., Hoppel, C.L., & Gunning, W.T. (1991). Carnitine deficiency associated with ornithine transcarbamylase deficiency. Pediatr Neurol, 7, 196-9. doi:10.1016/0887-8994(91)90084-x |
| F.6086 |
McClead, R.E., Rozen, R., Fox, J., Rosenberg, L., Menke, J., Bickers, R., & Morrow, G. (Nov 1986). Clinical application of DNA analysis in a family with OTC deficiency. Am J Med Genet, 25, 513-8. doi:10.1002/ajmg.1320250313 |
| F.6095 |
McInnes, R.R., Arshinoff, S.A., Bell, L., & McCulloch, C. (1980). Treatment of gyrate atrophy of the choroid and retina with low arginine diet. Trans Am Ophthalmol Soc, 78:226-42. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7257057 |
| F.6096 |
McInnes, R.R., Arshinoff, S.A., Bell, L., Marliss, E.B., & McCulloch, J.C. (Mar 1981). Hyperornithinaemia and gyrate atrophy of the retina: improvement of vision during treatment with a low-arginine diet. Lancet, 1, 513-6. doi:10.1016/s0140-6736(81)92858-0 |
| F.6114 |
Mehta, S., Tayabali, S., & Lachmann, R. (May 2018). Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report. J Med Case Rep, 12, 134. doi:10.1186/s13256-018-1666-3 |
| F.6119 |
Melnyk, A.R., Matalon, R., Henry, B.W., Zeller, W.P., & Lange, C. (Jan 1993). Prospective management of a child with neonatal citrullinemia. J Pediatr, 122, 96-8. doi:10.1016/s0022-3476(05)83497-3 |
| F.6121 |
members of the Urea Cycle Disorders Consoritum, McGuire, P.J., Lee, H.S., & Summar, M.L. (Dec 2013). Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders. J Pediatr, 163, 1705-1710.e1. doi:10.1016/j.jpeds.2013.08.029 |
| F.6122 |
Members of the Urea Cycle Disorders Consortium, Batshaw, M.L., Tuchman, M., Summar, M., & Seminara, J. (2014). A longitudinal study of urea cycle disorders. Mol Genet Metab, 113, 127-30. doi:10.1016/j.ymgme.2014.08.001 |
| F.6123 |
Members of the Urea Cycle Disorders Consortium, Burrage, L.C., Jain, M., Gandolfo, L., Lee, B.H., & Nagamani, S.C. (2014). Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders. Mol Genet Metab, 113, 131-5. doi:10.1016/j.ymgme.2014.06.005 |
| F.7973 |
Members of the Urea Cycle Disorders Consortium, Nagamani, S.C., Shchelochkov, O.A., Mullins, M.A., Carter, S., Lanpher, B.C., Sun, Q., Kleppe, S., Erez, A., O'Brian Smith, E., Marini, J.C., & Lee, B. (Nov 2012). A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria. Mol Genet Metab, 107, 315-21. doi:10.1016/j.ymgme.2012.09.016 |
| F.6128 |
Mendez-Figueroa, H., Lamance, K., Sutton, V.R., Aagaard-Tillery, K., & Van den Veyver, I. (Nov 2010). Management of ornithine transcarbamylase deficiency in pregnancy. Am J Perinatol, 27, 775-84. doi:10.1055/s-0030-1254240 |
| F.6132 |
Mercimek-Mahmutoglu, S., Moeslinger, D., Häberle, J., Engel, K., Herle, M., Strobl, M.W., Scheibenreiter, S., Muehl, A., & Stöckler-Ipsiroglu, S. (May 2010). Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria. Mol Genet Metab, 100, 24-8. doi:10.1016/j.ymgme.2010.01.013 |
| F.6149 |
Michel, M., Blatsios, G., Scholl-Bürgi, S., Entenmann, A., Wernstedt, A., Zschocke, A., Pichler, K., Höller, A., & Karall, D. (Sep 2015). Gyrate Atrophy in 2 Siblings - Ophthalmological Findings and A New Mutation. Klin Padiatr, 227, 296-8. doi:10.1055/s-0035-1555921 |
| F.6156 |
Mikołajek-Bedner, W., Torbé, A., Kwiatkowski, S., Michalczyk, M., Gizewska, M., Rokicki, D., Rzepka, R., Konstanty-Kurkiewicz, V., Domański, M., & Czajka, R. (Jul 2013). Pregnancy delivery and puerperium in a patient with lysinuric protein intolerance--a case report. Ginekol Pol, 84, 654-6. doi:10.17772/gp/1621 |
| F.6357 |
Mitchell, S., Welch-Burke, T., Dumitrescu, L., Lomenick, J.P., Murdock, D.G., Crawford, D.C., & Summar, M. (May 2012). Peptide tyrosine tyrosine levels are increased in patients with urea cycle disorders. Mol Genet Metab, 106, 39-42. doi:10.1016/j.ymgme.2012.02.011 |
| F.6363 |
Miyamoto, R., Sada, J., Ota, K., Kaneko, K., Kusano, H., Azuma, Y., & Okumura, A. (May 2021). Neonatal intrahepatic cholestasis caused by citrin deficiency with no hepatic steatosis: a case report. BMC Pediatr, 21, 237. doi:10.1186/s12887-021-02717-w |
| F.6366 |
Mizutani, N., Kato, T., Maehara, M., Watanabe, K., & Ban, M. (Jan 1984). Oral administration of arginine and citrulline in the treatment of lysinuric protein intolerance. Tohoku J Exp Med, 142, 15-24. doi:10.1620/tjem.142.15 |
| F.6367 |
Mizutani, N., Maehara, M., Hayakawa, C., Kato, T., Watanabe, K., & Suzuki, S. (1983). Hyperargininemia: clinical course and treatment with sodium benzoate and phenylacetic acid. Brain Dev, 5, 555-63. doi:10.1016/s0387-7604(83)80059-x |
| F.6580 |
Mohamed, S., Hamad, M.H., Kondkar, A.A., & Abu-Amero, K.K. (Oct 2015). A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia. Saudi Med J, 36, 1229-32. doi:10.15537/smj.2015.10.12127 |
| F.6583 |
Moien-Afshari, F., Mirhosseini, N.Z., Lemire, E.G., & Voll, C.L. (Mar 2016). An Acute Encephalopathy Accelerated by a Large Amount of Milk Consumption. Can J Neurol Sci, 43, 345-6. doi:10.1017/cjn.2015.297 |
| F.6602 |
Mori, T., Nagai, K., Mori, M., Nagao, M., Imamura, M., Iijima, M., & Kobayashi, K. (2002). Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency. Pediatr Dev Pathol, 5, 597-601. doi:10.1007/s10024-002-0109-7 |
| F.6603 |
Mori, T., Tsuchiyama, A., Nagai, K., Nagao, M., Oyanagi, K., & Tsugawa, S. (Jan 1990). A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency--L-carnitine treatment of CPS-I deficiency. Eur J Pediatr, 149, 272-4. doi:10.1007/BF02106292 |
| F.6609 |
Morris, A.A., Richmond, S.W., Oddie, S.J., Pourfarzam, M., Worthington, V., & Leonard, J.V. (Dec 1998). N-acetylglutamate synthetase deficiency: favourable experience with carbamylglutamate. J Inherit Metab Dis, 21, 867-8. doi:10.1023/a:1005478904186 |
| F.6614 |
Msall, M., Batshaw, M.L., Suss, R., Brusilow, S.W., & Mellits, E.D. (Jun 1984). Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med, 310, 1500-5. doi:10.1056/NEJM198406073102304 |
| F.6638 |
Nagasaka, H., Yorifuji, T., Egawa, H., Kikuta, H., Tanaka, K., & Kobayashi, K. (Mar 2001). Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency. J Pediatr, 138, 432-4. doi:10.1067/mpd.2001.111318 |
| F.6423 |
Nagasaka, H., Yorifuji, T., Murayama, K., Kubota, M., Kurokawa, K., Murakami, T., Kanazawa, M., Takatani, T., Ogawa, A., Ogawa, E., Yamamoto, S., Adachi, M., Kobayashi, K., & Takayanagi, M. (Sep 2006). Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency. Eur J Pediatr, 165, 618-24. doi:10.1007/s00431-006-0143-y |
| F.6648 |
Nakajima, H., & Fukuhara, S. (Jan 2022). Two Japanese siblings with arginase-1 deficiency identified using a novel frameshift mutation of (p.Lys41Thrfs2). J Pediatr Endocrinol Metab, 35, 125-129. doi:10.1515/jpem-2021-0436 |
| F.6649 |
Nakajima, M., Ishii, S., Mito, T., Takeshita, K., Takashima, S., Takakura, H., Inoue, I., Saheki, T., Akiyoshi, H., & Ichihara, K. (1988). Clinical, biochemical and ultrastructural study on the pathogenesis of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Brain Dev, 10, 181-5. doi:10.1016/s0387-7604(88)80025-1 |
| F.6650 |
Nakamura, K., Kido, J., Matsumoto, S., Mitsubuchi, H., & Endo, F. (Jul 2016). Clinical manifestations and growth of patients with urea cycle disorders in Japan. J Hum Genet, 61, 613-6. doi:10.1038/jhg.2016.17 |
| F.6651 |
Nakamura, K., Kido, J., Mitsubuchi, H., & Endo, F. (Aug 2014). Diagnosis and treatment of urea cycle disorder in Japan. Pediatr Int, 56, 506-9. doi:10.1111/ped.12439 |
| F.6660 |
Nandhagopal, R., Al-Murshedi, F., Al-Busaidi, M., & Al-Busaidi, A. (Jan 2018). Encephalopathy mimicking non-convulsive status Epilepticus. Neurosciences (Riyadh), 23, 52-56. doi:10.17712/nsj.2018.1.20170214 |
| G.203 |
National Urea Cycle Disorders Foundation. (2025). Patient survey data: Puberty. NUCDF. |
| F.6678 |
Nänto-Salonen, K., Komu, M., Lundbom, N., Heinänen, K., Alanen, A., Sipilä, I., & Simell, O. (Jul 1999). Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology, 53, 303-7. doi:10.1212/wnl.53.2.303 |
| F.6687 |
Newnham, T., Hardikar, W., Allen, K., Wellard, R.M., Hamilton, C., Angus, P., Jones, R., & Boneh, A. (Jan 2008). Liver transplantation for argininosuccinic aciduria: clinical, biochemical, and metabolic outcome. Liver Transpl, 14, 41-5. doi:10.1002/lt.21297 |
| F.6696 |
Nicolaides, P., Liebsch, D., Dale, N., Leonard, J., & Surtees, R. (Jan 2002). Neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch Dis Child, 86, 54-6. doi:10.1136/adc.86.1.54 |
| F.6702 |
Ninković, D., Mustapić, Ž., Bartoniček, D., Benjak, V., Ćuk, M., Buljević, A.D., Grčić, B.F., Fumić, K., Grizelj, R., Lehman, I., Ramadža, D.P., Sarnavka, V., Slaviček, J., Kastelić, J.S., Barišić, N., & Barić, I. (Mar 2019). The Therapeutic Hypothermia in Treatment of Hyperammonemic Encephalopathy due to Urea Cycle Disorders and Organic Acidemias. Klin Padiatr, 231, 74-79. doi:10.1055/a-0855-4001 |
| F.6713 |
Noguchi, A., Nakamura, K., Murayama, K., Yamamoto, S., Komatsu, H., Kizu, R., Takayanagi, M., Okuyama, T., Endo, F., Takasago, Y., Shoji, Y., & Takahashi, T. (Oct 2016). Clinical and genetic features of lysinuric protein intolerance in Japan. Pediatr Int, 58, 979-983. doi:10.1111/ped.12946 |
| F.6739 |
Nyhan, W.L., Wolff, J., Kulovich, S., & Shumacher, A.E. (Jan 1985). Intestinal obstruction due to peritoneal adhesions as a complication of peritoneal dialysis for neonatal hyperammonemia. Eur J Pediatr, 143, 211-3. doi:10.1007/BF00442141 |
| F.6756 |
Ogier de Baulny, H. (Feb 2002). Management and emergency treatments of neonates with a suspicion of inborn errors of metabolism. Semin Neonatol, 7, 17-26. doi:10.1053/siny.2001.0084 |
| F.6765 |
Ohkubo, Y., Ueta, A., Ito, T., Sumi, S., Yamada, M., Ozawa, K., & Togari, H. (Apr 2005). Vitamin B6-responsive ornithine aminotransferase deficiency with a novel mutation G237D. Tohoku J Exp Med, 205, 335-42. doi:10.1620/tjem.205.335 |
| F.6770 |
Ohtani, Y., Ohyanagi, K., Yamamoto, S., & Matsuda, I. (Mar 1988). Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency. J Pediatr, 112, 409-14. doi:10.1016/s0022-3476(88)80321-4 |
| F.6772 |
Ohura, T., Kobayashi, K., Tazawa, Y., Abukawa, D., Sakamoto, O., Tsuchiya, S., & Saheki, T. (Apr 2007). Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). J Inherit Metab Dis, 30, 139-44. doi:10.1007/s10545-007-0506-1 |
| F.6781 |
Okano, Y., Okamoto, M., Yazaki, M., Inui, A., Ohura, T., Murayama, K., Watanabe, Y., Tokuhara, D., & Takeshima, Y. (May 2021). Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: Towards prevention of adult-onset type II citrullinemia. Mol Genet Metab, 133, 63-70. doi:10.1016/j.ymgme.2021.03.004 |
| F.6787 |
Olgac, A., Kasapkara, Ç.S., Kilic, M., Emine Derinkuyu, B., Azapagasi, E., Kesici, S., Biberoğlu, G., Ozyazici, A., Karaca, M., & Haberle, J. (Dec 2020). A rare urea cycle disorder in a neonate: N-acetylglutamate synthetase deficiency. Arch Argent Pediatr, 118, e545-e548. doi:10.5546/aap.2020.eng.e545 |
| F.6788 |
Olgac, A., Kasapkara, C.S., Kilic, M., Keskin, E.Y., Sandal, G., Cram, D.S., Haberle, J., & Torun, D. (Aug 2020). Carbonic anhydrase VA deficiency: a very rare case of hyperammonemic encephalopathy. J Pediatr Endocrinol Metab, 33, 1349-1352. doi:10.1515/jpem-2020-0117 |
| F.6789 |
Olgac, A., Yildiz, E., Yilmaz, A., Kasapkara, C.S., Ceylaner, S., & Alioglu, B. (Dec 2022). A Delayed Presentation of Arginase Deficiency Presenting with Status Epilepticus. J Coll Physicians Surg Pak, 32, 1629-1631. doi:10.29271/jcpsp.2022.12.1629 |
| F.6794 |
Ono, H., Suto, T., Kinoshita, Y., Sakano, T., Furue, T., & Ohta, T. (Nov 2009). A case of carbamoyl phosphate synthetase 1 deficiency presenting symptoms at one month of age. Brain Dev, 31, 779-81. doi:10.1016/j.braindev.2008.12.013 |
| F.6795 |
Ono, H., Tamada, T., & Shigematsu, Y. (Aug 2018). Lactate/pyruvate in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Pediatr Int, 60, 762-764. doi:10.1111/ped.13608 |
| F.6796 |
Ono, N., Kishida, K., Tokumoto, K., Watanabe, M., Shimada, Y., Yoshinaga, J., & Fujii, M. (Jan 1992). Lysinuric protein intolerance presenting deficiency of argininosuccinate synthetase. Intern Med, 31, 55-9. doi:10.2169/internalmedicine.31.55 |
| F.6804 |
Origuchi, Y., Ushijima, T., Sakaguchi, M., Akaboshi, I., & Matsuda, I. (1984). Citrullinemia presenting as uncontrollable epilepsy. Brain Dev, 6, 328-31. doi:10.1016/s0387-7604(84)80047-9 |
| F.6805 |
Osada, H., & Seki, K. (2006). Amino acid changes during successful pregnancy in a case of lysinuric protein insufficiency. Gynecol Obstet Invest, 61, 139-41. doi:10.1159/000090410 |
| F.6816 |
Ozcan, O.U., Turhan, S., Vurgun, V.K., & Erol, C. (2015). Atrioventricular block in siblings with argininosuccinic aciduria. Int J Cardiol, 189, 109-11. doi:10.1016/j.ijcard.2015.03.407 |
| F.6838 |
Panlaqui, O.M., Tran, K., Johns, A., McGill, J., & White, H. (Oct 2008). Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency. Intensive Care Med, 34, 1922-4. doi:10.1007/s00134-008-1217-2 |
| F.6848 |
Parini, R., Vegni, M., Pontiggia, M., Melotti, D., Corbetta, C., Rossi, A., & Piceni Sereni, L. (1991). A difficult diagnosis of lysinuric protein intolerance: association with glucose-6-phosphate dehydrogenase deficiency. J Inherit Metab Dis, 14, 833-4. doi:10.1007/BF01799959 |
| F.6860 |
Parsons, H., Snyder, F., Bowen, T., Klassen, J., & Pinto, A. (1996). Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance. J Inherit Metab Dis, 19, 627-34. doi:10.1007/BF01799838 |
| F.6861 |
Parsons, H.G., Scott, R.B., Pinto, A., Carter, R.J., & Snyder, F.F. (1987). Argininosuccinic aciduria: long-term treatment with arginine. J Inherit Metab Dis, 10, 152-61. doi:10.1007/BF01800042 |
| F.6863 |
Parto, K., Penttinen, R., Paronen, I., Pelliniemi, L., & Simell, O. (1993). Osteoporosis in lysinuric protein intolerance. J Inherit Metab Dis, 16, 441-50. doi:10.1007/BF00710296 |
| F.6864 |
Parto, K., Svedström, E., Majurin, M.L., Härkönen, R., & Simell, O. (Oct 1993). Pulmonary manifestations in lysinuric protein intolerance. Chest, 104, 1176-82. doi:10.1378/chest.104.4.1176 |
| F.6865 |
Pascual, J.C., Matarredona, J., & Mut, J. (2007). Acrodermatitis enteropathica-like dermatosis associated with ornithine transcarbamylase deficiency. Pediatr Dermatol, 24, 394-6. doi:10.1111/j.1525-1470.2007.00457.x |
| F.6868 |
Patel, H., Kim, J., & Huncke, T.K. (Sep 2016). General anesthesia in a patient with citrullinemia using Precedex as an adjunct to prevent delayed emergence. J Clin Anesth, 33, 403-5. doi:10.1016/j.jclinane.2016.04.045 |
| F.6945 |
Pembrey, M.E., Old, J.M., Leonard, J.V., Rodeck, C.H., Warren, R., & Davies, K.E. (Dec 1985). Prenatal diagnosis of ornithine carbamoyl transferase deficiency using a gene specific probe. J Med Genet, 22, 462-5. doi:10.1136/jmg.22.6.462 |
| F.6940 |
Perito, E.R., Rhee, S., Roberts, J.P., & Rosenthal, P. (Jan 2014). Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012. Liver Transpl, 20, 89-99. doi:10.1002/lt.23765 |
| F.6935 |
Peterson, D.E. (Nov 2003). Acute postpartum mental status change and coma caused by previously undiagnosed ornithine transcarbamylase deficiency. Obstet Gynecol, 102, 1212-5. doi:10.1016/s0029-7844(03)00165-0 |
| F.6933 |
Phillips, M.R., Schwartz, S.P., Smith, M.M., Leung, D., McLean, S.E., & Clement, K.C. (Feb 2022). Neonatal ECMO for Cardiopulmonary Failure Due to Carbamoyl Phosphate Synthetase I Deficiency. Am Surg, 88, 306-307. doi:10.1177/0003134820940630 |
| F.6930 |
Pichler, K., Michel, M., Zlamy, M., Scholl-Buergi, S., Ralser, E., Jörg-Streller, M., & Karall, D. (Apr 2017). Breast milk feeding in infants with inherited metabolic disorders other than phenylketonuria - a 10-year single-center experience. J Perinat Med, 45, 375-382. doi:10.1515/jpm-2016-0205 |
| F.6899 |
Pitkänen, H.H., Kärki, M., Niinikoski, H., Tanner, L., Näntö-Salonen, K., Pikta, M., Kopatz, W.F., Zuurveld, M., Meijers, J.C.M., Brinkman, H.J.M., & Lassila, R. (Sep 2018). Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment. Haemophilia, 24, e312-e321. doi:10.1111/hae.13543 |
| F.6902 |
Plecko, B., Erwa, W., & Wermuth, B. (Dec 1998). Partial N-acetylglutamate synthetase deficiency in a 13-year-old girl: diagnosis and response to treatment with N-carbamylglutamate. Eur J Pediatr, 157, 996-8. doi:10.1007/s004310050985 |
| F.6918 |
Pontoizeau, C., Roda, C., Arnoux, J.B., Vignolo-Diard, P., Brassier, A., Habarou, F., Barbier, V., Grisel, C., Abi-Warde, M.T., Boddaert, N., Kuster, A., Servais, A., Kaminska, A., Hennequin, C., Dupic, L., Lesage, F., Touati, G., Valayannopoulos, V., Chadefaux-Vekemans, B., Oualha, M., Eisermann, M., Ottolenghi, C., & de Lonlay, P. (Jun 2020). Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disorders. Mol Genet Metab, 130, 110-117. doi:10.1016/j.ymgme.2020.03.003 |
| F.6915 |
Porta, F., Peruzzi, L., Bonaudo, R., Pieretti, S., Busso, M., Cocchi, E., Conio, A., Pagliardini, V., & Spada, M. (Oct 2018). Differential response to renal replacement therapy in neonatal-onset inborn errors of metabolism. Nephrology (Carlton), 23, 957-961. doi:10.1111/nep.13409 |
| F.6498 |
Praphanphoj, V., Boyadjiev, S.A., Waber, L.J., Brusilow, S.W., & Geraghty, M.T. (Mar 2000). Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia. J Inherit Metab Dis, 23, 129-36. doi:10.1023/a:1005661631281 |
| F.6978 |
Qadri, S.K., Ting, T.W., Lim, J.S., & Jamuar, S.S. (Dec 2016). Milder Form of Urea Cycle Defect Revisited: Report and Review of Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria (HHH) Syndrome Diagnosed in a Teenage Girl Presenting with Recurrent Encephalopathy. Ann Acad Med Singap, 45(12):563-566. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28062886 |
| F.6987 |
Qureshi, I.A., Letarte, J., Ouellet, R., Batshaw, M.L., & Brusilow, S. (Mar 1984). Treatment of hyperargininemia with sodium benzoate and arginine-restricted diet. J Pediatr, 104, 473-6. doi:10.1016/s0022-3476(84)81120-8 |
| F.6992 |
Rabier, D., Narcy, C., Bardet, J., Parvy, P., Saudubray, J.M., & Kamoun, P. (1991). Arginine remains an essential amino acid after liver transplantation in urea cycle enzyme deficiencies. J Inherit Metab Dis, 14, 277-80. doi:10.1007/BF01811681 |
| F.6999 |
Raghavan, K., Chabra, S., Mondkar, J., Aiyar, R., Ambani, L.M., & Fernandez, A. (May 1991). Carbamylphosphate synthetase-I deficiency in a newborn: survival after early diagnosis and therapy. Indian Pediatr, 28(5):551-4. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1752685 |
| F.7500 |
Rajantie, J., Rapola, J., & Siimes, M.A. (Jan 1981). Ferritinemia with subnormal iron stores in lysinuric protein intolerance. Metabolism, 30, 3-5. doi:10.1016/0026-0495(81)90211-0 |
| F.7501 |
Rajantie, J., Simell, O., & Perheentupa, J. (Jan 1983). Oral administration of urea cycle intermediates in lysinuric protein intolerance: effect on plasma and urinary arginine and ornithine. Metabolism, 32, 49-51. doi:10.1016/0026-0495(83)90154-3 |
| F.7507 |
Rajantie, J., Simell, O., & Perheentupa, J. (Jun 1980). Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. Gut, 21, 519-24. doi:10.1136/gut.21.6.519 |
| F.7505 |
Rajantie, J., Simell, O., Perheentupa, J., & Siimes, M.A. (Nov 1980). Changes in peripheral blood cells and serum ferritin in lysinuric protein intolerance. Acta Paediatr Scand, 69, 741-5. doi:10.1111/j.1651-2227.1980.tb07143.x |
| F.7504 |
Rajantie, J., Simell, O., Rapola, J., & Perheentupa, J. (Dec 1980). Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine. J Pediatr, 97, 927-32. doi:10.1016/s0022-3476(80)80422-7 |
| F.7523 |
Redonnet-Vernhet, I., Rouanet, F., Pedespan, J.M., Hocke, C., & Parrot, F. (Feb 2000). A successful pregnancy in a heterozygote for OTC deficiency treated with sodium phenylbutyrate. Neurology, 54, 1008. doi:10.1212/wnl.54.4.1008 |
| F.7526 |
Reid, L., Perreault, E., Lafrance, G., & Clarke, J.T. (Dec 2009). Experience with the treatment of argininosuccinic aciduria during pregnancy. J Inherit Metab Dis, 32 Suppl 1, S191-5. doi:10.1007/s10545-009-1145-5 |
| F.7535 |
Rigante, D., Savastano, M.C., Leone, A., Falsini, B., Baldascino, A., La Torraca, I., Lepore, D., De Nisco, A., Sacco, E., & Minnella, A.M. (Oct 2010). Occipital porencephaly in a child with gyrate atrophy of the choroid and retina. J AAPOS, 14, 462-4. doi:10.1016/j.jaapos.2010.07.011 |
| F.7664 |
Rodan, L.H., Aldubayan, S.H., Berry, G.T., & Levy, H.L. (Jun 2018). Acute Illness Protocol for Urea Cycle Disorders. Pediatr Emerg Care, 34, e115-e119. doi:10.1097/PEC.0000000000001298 |
| F.7967 |
Rodney, S., & Boneh, A. (2013). Amino Acid Profiles in Patients with Urea Cycle Disorders at Admission to Hospital due to Metabolic Decompensation. JIMD Rep, 9, 97-104. doi:10.1007/8904_2012_186 |
| F.7682 |
Roze, E., Azuar, C., Menuel, C., Häberle, J., & Guillevin, R. (Sep 2007). Usefulness of magnetic resonance spectroscopy in urea cycle disorders. Pediatr Neurol, 37, 222-5. doi:10.1016/j.pediatrneurol.2007.05.003 |
| F.7696 |
Saheki, T., Kobayashi, K., Terashi, M., Ohura, T., Yanagawa, Y., Okano, Y., Hattori, T., Fujimoto, H., Mutoh, K., Kizaki, Z., & Inui, A. (Jun 2008). Reduced carbohydrate intake in citrin-deficient subjects. J Inherit Metab Dis, 31, 386-94. doi:10.1007/s10545-008-0752-x |
| F.7708 |
Sanjurjo, P., Rodríguez-Soriano, J., Vallo, A., Arranz, A., & Rubio, V. (Aug 1991). Neonatal citrullinaemia with satisfactory mental development. Eur J Pediatr, 150, 730-1. doi:10.1007/BF01958766 |
| F.7711 |
Santos Silva, E., Martins, E., Cardoso, M.L., Barbot, C., Vilarinho, L., & Medina, M. (Dec 2001). Liver transplantation in a case of argininaemia. J Inherit Metab Dis, 24, 885-7. doi:10.1023/a:1013960712516 |
| F.7873 |
Scaglia, F. (2010). New insights in nutritional management and amino acid supplementation in urea cycle disorders. Mol Genet Metab, 100 Suppl 1, S72-6. doi:10.1016/j.ymgme.2010.02.019 |
| F.7874 |
Scaglia, F., Carter, S., O'Brien, W.E., & Lee, B. (Apr 2004). Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients. Mol Genet Metab, 81 Suppl 1, S79-85. doi:10.1016/j.ymgme.2003.11.017 |
| F.7715 |
Schimanski, U., Krieger, D., Horn, M., Stremmel, W., Wermuth, B., & Theilmann, L. (Dec 1996). A novel two-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonia in early pregnancy. Hepatology, 24, 1413-5. doi:10.1053/jhep.1996.v24.pm0008938172 |
| F.7716 |
Schlune, A., Vom Dahl, S., Häussinger, D., Ensenauer, R., & Mayatepek, E. (Sep 2015). Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature. Amino Acids, 47, 1751-62. doi:10.1007/s00726-015-2032-z |
| F.7720 |
Schmidt, J., Kroeber, S., Irouschek, A., Birkholz, T., Schroth, M., & Albrecht, S. (Mar 2006). Anesthetic management of patients with ornithine transcarbamylase deficiency. Paediatr Anaesth, 16, 333-7. doi:10.1111/j.1460-9592.2005.01695.x |
| F.7623 |
Schubiger, G., Bachmann, C., Barben, P., Colombo, J.P., Tönz, O., & Schüpbach, D. (Mar 1991). N-acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication. Eur J Pediatr, 150, 353-6. doi:10.1007/BF01955939 |
| F.7728 |
Sebastio, G., Sperandeo, M.P., & Andria, G. (Feb 2011). Lysinuric protein intolerance: reviewing concepts on a multisystem disease. Am J Med Genet C Semin Med Genet, 157C, 54-62. doi:10.1002/ajmg.c.30287 |
| F.7757 |
Semenova, N., Marakhonov, A., Ampleeva, M., Kurkina, M., Baydakova, G., Skoblov, M., Taran, N., Babak, O., Shchukina, E., & Strokova, T. (Nov 2022). Hyperammonemia in Russia Due to Carbonic Anhydrase VA Deficiency Caused by Homozygous Mutation p.Lys185Lys (c.555G>A) of the CA5A Gene. Int J Mol Sci, 23, . doi:10.3390/ijms232315026 |
| F.7762 |
Serrano, M., Martins, C., Pérez-Dueñas, B., Gómez-López, L., Murgui, E., Fons, C., García-Cazorla, A., Artuch, R., Jara, F., Arranz, J.A., Häberle, J., Briones, P., Campistol, J., Pineda, M., & Vilaseca, M.A. (Mar 2010). Neuropsychiatric manifestations in late-onset urea cycle disorder patients. J Child Neurol, 25, 352-8. doi:10.1177/0883073809340696 |
| F.7763 |
Serrano, M., Ormazábal, A., Vilaseca, M.A., Lambruschini, N., Garcia-Romero, R., Meavilla, S., Perez-Dueñas, B., Pineda, M., Garcia-Cazorla, A., Campistol, J., & Artuch, R. (Jun 2011). Assessment of plasma ammonia and glutamine concentrations in urea cycle disorders. Clin Biochem, 44, 742-4. doi:10.1016/j.clinbiochem.2011.03.136 |
| F.7767 |
Shaw, P.J., Dale, G., & Bates, D. (May 1989). Familial lysinuric protein intolerance presenting as coma in two adult siblings. J Neurol Neurosurg Psychiatry, 52, 648-51. doi:10.1136/jnnp.52.5.648 |
| F.7880 |
Shih, V.E., Berson, E.L., & Gargiulo, M. (Jul 1981). Reduction of hyperornithinemia with a low protein, low arginine diet and pyridoxine in patients with a deficiency of ornithine-ketoacid transaminase (OKT) activity and gyrate atrophy of the choroid and retina. Clin Chim Acta, 113, 243-51. doi:10.1016/0009-8981(81)90278-3 |
| F.7949 |
Shinawi, M., Dietzen, D.J., White, F.V., Sprietsma, L., & Weymann, A. (Dec 2011). Early-onset hepatic fibrosis in lysinuric protein intolerance. J Pediatr Gastroenterol Nutr, 53, 695-8. doi:10.1097/MPG.0b013e318227b02d |
| F.7944 |
Shrestha, S.P., Arora, R., Pradhan, R., & Bhatt, S. (Nov 2010). First reported cases of gyrate atrophy of the choroid from Nepal. BMJ Case Rep, 2010, . doi:10.1136/bcr.04.2010.2951 |
| F.7800 |
Sinclair, M., Ket, S., Testro, A., Gow, P.J., & Angus, P.W. (Feb 2014). Acute hepatic decompensation precipitated by pregnancy-related catabolic stress: a rare mimic of acute liver failure. Obstet Gynecol, 123, 480-483. doi:10.1097/AOG.000000000000005 |
| F.7801 |
Singh, R.H. (Nov 2007). Nutritional management of patients with urea cycle disorders. J Inherit Metab Dis, 30, 880-7. doi:10.1007/s10545-007-0718-4 |
| F.7802 |
Singh, R.H., Rhead, W.J., Smith, W., Lee, B., Sniderman King, L., & Summar, M. (Oct 2005). Nutritional management of urea cycle disorders. Crit Care Clin, 21, S27-35. doi:10.1016/j.ccc.2005.08.003 |
| F.7806 |
Sipilä, I., Rapola, J., Simell, O., & Vannas, A. (Apr 1981). Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med, 304, 867-70. doi:10.1056/NEJM198104093041503 |
| F.7953 |
Smith, L., Lambert, M.A., Brochu, P., Jasmin, G., Qureshi, I.A., & Seidman, E.G. (Nov 1992). Hyperornithinemia, hyperammonemia, homocitrullinuria (HHH) syndrome: presentation as acute liver disease with coagulopathy. J Pediatr Gastroenterol Nutr, 15, 431-6. doi:10.1097/00005176-199211000-00011 |
| F.7941 |
Smith, W., Kishnani, P.S., Lee, B., Singh, R.H., Rhead, W.J., Sniderman King, L., Smith, M., & Summar, M. (Oct 2005). Urea cycle disorders: clinical presentation outside the newborn period. Crit Care Clin, 21, S9-17. doi:10.1016/j.ccc.2005.05.007 |
| F.7824 |
Sniderman King, L., Singh, R.H., Rhead, W.J., Smith, W., Lee, B., & Summar, M.L. (Oct 2005). Genetic counseling issues in urea cycle disorders. Crit Care Clin, 21, S37-44. doi:10.1016/j.ccc.2005.08.001 |
| F.7882 |
Song, Y.Z., Li, B.X., Chen, F.P., Liu, S.R., Sheng, J.S., Ushikai, M., Zhang, C.H., Zhang, T., Wang, Z.N., Kobayashi, K., Saheki, T., & Zheng, X.Y. (Sep 2009). Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China. Dig Liver Dis, 41, 683-9. doi:10.1016/j.dld.2008.11.014 |
| F.7960 |
Soulpis, C., Markosoglou, D., Papadelis, F., Caraboula, A., Giouroukos, S., Skarpalezou, A., Missìou-Tsagarakis, S., & Michelakakis, H. (1991). Ornithine transcarbamylase deficiency: findings and treatment in a symptomatic female heterozygote. J Inherit Metab Dis, 14, 107-8. doi:10.1007/BF01804398 |
| F.7899 |
Sperl, W., Geiger, R., Maurer, H., Murr, C., Schmoigl, C., Steichen-Gersdorf, E., & Sailer, M. (1992). Continuous arteriovenous haemofiltration in a neonate with hyperammonaemic coma due to citrullinaemia. J Inherit Metab Dis, 15, 158-9. doi:10.1007/BF01800361 |
| F.7898 |
Spinale, J.M., Laskin, B.L., Sondheimer, N., Swartz, S.J., & Goldstein, S.L. (Jun 2013). High-dose continuous renal replacement therapy for neonatal hyperammonemia. Pediatr Nephrol, 28, 983-6. doi:10.1007/s00467-013-2441-8 |
| F.7885 |
Stapleton, C., Boulter, E., & Balasubramaniam, S. (Dec 2017). Citrin deficiency: A rare but important metabolic disorder to consider in infants with faltering growth and hyperbilirubinaemia. J Paediatr Child Health, 53, 1229-1232. doi:10.1111/jpc.13670 |
| F.7961 |
Stöckler, S., Grossschädl, F., Bachmann, C., & Roscher, A. (1987). Ornithine transcarbamylase variant in a male patient. J Inherit Metab Dis, 10, 272. doi:10.1007/BF01800077 |
| F.7615 |
Stoppoloni, G., Prisco, F., Santinelli, R., Sicuranza, G., & Rinaldi, E. (Apr 1982). Treatment of hyperornithinaemia and gyrate atrophy of choroid and retina with low-protein diet. Lancet, 1, 973. doi:10.1016/s0140-6736(82)91981-x |
| G.195 |
Suares, C., & Burfield, J. (2021, June 23). A discussion with dietitians on supporting women with UCDs throughout pregnancy [Commentary and analysis of practice & research]. UCLA Health and Children's Hospital of Pennsylvania. |
| F.7597 |
Summar, M. (Jan 2001). Current strategies for the management of neonatal urea cycle disorders. J Pediatr, 138, S30-9. doi:10.1067/mpd.2001.111834 |
| F.7596 |
Summar, M., Pietsch, J., Deshpande, J., & Schulman, G. (Mar 1996). Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia. J Pediatr, 128, 379-82. doi:10.1016/s0022-3476(96)70287-1 |
| F.7594 |
Summar, M.L., & Mew, N.A. (Apr 2018). Inborn Errors of Metabolism with Hyperammonemia: Urea Cycle Defects and Related Disorders. Pediatr Clin North Am, 65, 231-246. doi:10.1016/j.pcl.2017.11.004 |
| F.7593 |
Summar, M.L., Barr, F., Dawling, S., Smith, W., Lee, B., Singh, R.H., Rhead, W.J., Sniderman King, L., & Christman, B.W. (Oct 2005). Unmasked adult-onset urea cycle disorders in the critical care setting. Crit Care Clin, 21, S1-8. doi:10.1016/j.ccc.2005.05.002 |
| F.7590 |
Summar, M.L., Dobbelaere, D., Brusilow, S., & Lee, B. (Oct 2008). Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr, 97, 1420-5. doi:10.1111/j.1651-2227.2008.00952.x |
| F.7582 |
Svedström, E., Parto, K., Marttinen, M., Virtama, P., & Simell, O. (1993). Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients. Skeletal Radiol, 22, 11-6. doi:10.1007/BF00191519 |
| F.6226 |
Tabanlioğlu, D., Ersoy-Evans, S., & Karaduman, A. (2009). Acrodermatitis enteropathica-like eruption in metabolic disorders: acrodermatitis dysmetabolica is proposed as a better term. Pediatr Dermatol, 26, 150-4. doi:10.1111/j.1525-1470.2008.00803.x |
| F.6224 |
Takada, G., Goto, A., Komatsu, K., & Goto, R. (Dec 1987). Carnitine deficiency in lysinuric protein intolerance: lysine-sparing effect of carnitine. Tohoku J Exp Med, 153, 331-4. doi:10.1620/tjem.153.331 |
| F.5562 |
Takayama, N., Hamada, H., & Kubo, T. (1995). Lysinuric protein intolerance in pregnancy: case report with successful outcome. Arch Gynecol Obstet, 256, 49-52. doi:10.1007/BF00634350 |
| F.5561 |
Takeda, E., Kuroda, Y., Toshima, K., Watanabe, T., Naito, E., & Miyao, M. (Mar 1983). Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency. Clin Pediatr (Phila), 22, 206-8. doi:10.1177/000992288302200309 |
| F.6200 |
Tanaka, K., Nakamura, K., Matsumoto, S., Kido, J., Mitsubuchi, H., Ohura, T., & Endo, F. (Apr 2017). Citrulline for urea cycle disorders in Japan. Pediatr Int, 59, 422-426. doi:10.1111/ped.13163 |
| F.6189 |
Tanner, L., Näntö-Salonen, K., Niinikoski, H., Erkkola, R., Huoponen, K., & Simell, O. (Feb 2006). Hazards associated with pregnancies and deliveries in lysinuric protein intolerance. Metabolism, 55, 224-31. doi:10.1016/j.metabol.2005.08.016 |
| F.6194 |
Tanner, L.M., Näntö-Salonen, K., Niinikoski, H., Huoponen, K., & Simell, O. (Feb 2007). Long-term oral lysine supplementation in lysinuric protein intolerance. Metabolism, 56, 185-9. doi:10.1016/j.metabol.2006.09.011 |
| F.6190 |
Tanner, L.M., Näntö-Salonen, K., Niinikoski, H., Jahnukainen, T., Keskinen, P., Saha, H., Kananen, K., Helanterä, A., Metso, M., Linnanvuo, M., Huoponen, K., & Simell, O. (Jun 2007). Nephropathy advancing to end-stage renal disease: a novel complication of lysinuric protein intolerance. J Pediatr, 150, 631-4, 634.e1. doi:10.1016/j.jpeds.2007.01.043 |
| F.6191 |
Tanner, L.M., Näntö-Salonen, K., Rashed, M.S., Kotilainen, S., Aalto, M., Venetoklis, J., Niinikoski, H., Huoponen, K., & Simell, O. (Apr 2008). Carnitine deficiency and L-carnitine supplementation in lysinuric protein intolerance. Metabolism, 57, 549-54. doi:10.1016/j.metabol.2007.11.019 |
| F.6192 |
Tanner, L.M., Näntö-Salonen, K., Venetoklis, J., Kotilainen, S., Niinikoski, H., Huoponen, K., & Simell, O. (Oct 2007). Nutrient intake in lysinuric protein intolerance. J Inherit Metab Dis, 30, 716-21. doi:10.1007/s10545-007-0558-2 |
| F.6193 |
Tanner, L.M., Niinikoski, H., Näntö-Salonen, K., & Simell, O. (Dec 2010). Combined hyperlipidemia in patients with lysinuric protein intolerance. J Inherit Metab Dis, 33 Suppl 3, S145-50. doi:10.1007/s10545-010-9050-5 |
| F.6961 |
Terheggen, H.G., Lowenthal, A., & Colombo, J.P. (1982). Clinical and biochemical findings in argininemia. Adv Exp Med Biol, 153, 111-9. doi:10.1007/978-1-4757-6903-6_14 |
| F.6289 |
Thakur, V., Rupar, C.A., Ramsay, D.A., Singh, R., & Fraser, D.D. (May 2006). Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid. Pediatr Crit Care Med, 7, 273-6. doi:10.1097/01.PCC.0000216682.56067.23 |
| F.6276 |
Tihtonen, K., Uotila, J., Lähde, J., Salo, M., & Keskinen, P. (Mar 2010). Risk of hyperammonemic coma in the puerperium: two cases of women with diagnosed and undiagnosed deficiency of urea cycle enzymes. Acta Obstet Gynecol Scand, 89, 404-6. doi:10.3109/00016340903540646 |
| F.6489 |
Tonini, M.C., Bignamini, V., & Mattioli, M. (May 2011). Headache and neuropsychic disorders in the puerperium: a case report with suspected deficiency of urea cycle enzymes. Neurol Sci, 32 Suppl 1, S157-9. doi:10.1007/s10072-011-0518-3 |
| F.6262 |
Torkzaban, M., Haddad, A., Baxter, J.K., Berghella, V., Gahl, W.A., & Al-Kouatly, H.B. (Oct 2019). Maternal ornithine transcarbamylase deficiency, a genetic condition associated with high maternal and neonatal mortality every clinician should know: A systematic review. Am J Med Genet A, 179, 2091-2100. doi:10.1002/ajmg.a.61329 |
| F.7029 |
Tsuboi, Y., Fujino, Y., Kobayashi, K., Saheki, T., & Yamada, T. (Sep 2001). High serum pancreatic secretory trypsin inhibitor before onset of type II citrullinemia. Neurology, 57, 933. doi:10.1212/wnl.57.5.933 |
| F.6302 |
Tuchman, M., Mauer, S.M., Holzknecht, R.A., Summar, M.L., & Vnencak-Jones, C.L. (1992). Prospective versus clinical diagnosis and therapy of acute neonatal hyperammonaemia in two sisters with carbamyl phosphate synthetase deficiency. J Inherit Metab Dis, 15, 269-77. doi:10.1007/BF01799641 |
| F.6321 |
Uemoto, S., Yabe, S., Inomata, Y., Nishizawa, H., Asonuma, K., Egawa, H., Kiuchi, T., Okajima, H., Yamaoka, Y., Yamabe, H., Inui, A., Fujisawa, T., & Tanaka, K. (Apr 1997). Coexistence of a graft with the preserved native liver in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency. Transplantation, 63, 1026-8. doi:10.1097/00007890-199704150-00021 |
| F.6323 |
Unita, S., Hirashima, N., Shimada, M., Tsunekawa, T., Tanaka, D., Kondo, T., Urata, N., Kondo, H., Saito, M., Iwase, H., Ito, S., Togawa, T., Saitoh, S., & Tanaka, Y. (Oct 2020). Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and L-arginine after DNA analysis produced a definitive diagnosis. Clin J Gastroenterol, 13, 823-833. doi:10.1007/s12328-019-01083-6 |
| F.6481 |
Unsinn, C., Das, A., Valayannopoulos, V., Thimm, E., Beblo, S., Burlina, A., Konstantopoulou, V., Mayorandan, S., de Lonlay, P., Rennecke, J., Derbinski, J., Hoffmann, G.F., & Häberle, J. (Aug 2016). Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013. Orphanet J Rare Dis, 11, 116. doi:10.1186/s13023-016-0493-0 |
| F.6480 |
Urea Cycle Disorders Conference group. (Jan 2001). Consensus statement from a conference for the management of patients with urea cycle disorders. J Pediatr, 138, S1-5. doi:10.1067/mpd.2001.111830 |
| F.6328 |
Urea Cycle Disorders Consortium (UCDC), European registry and network for Intoxication type Metabolic Diseases (E-IMD), Posset, R., Garbade, S.F., Gleich, F., Gropman, A.L., de Lonlay, P., Hoffmann, G.F., Garcia-Cazorla, A., Nagamani, S.C.S., Baumgartner, M.R., Schulze, A., Dobbelaere, D., Yudkoff, M., Kölker, S., & Zielonka, M. (Jul 2020). Long-term effects of medical management on growth and weight in individuals with urea cycle disorders. Sci Rep, 10, 11948. doi:10.1038/s41598-020-67496-3 |
| F.6976 |
Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic Diseases Consortia Study Group, Posset, R., Gropman, A.L., Nagamani, S.C.S., Burrage, L.C., Bedoyan, J.K., Wong, D., Berry, G.T., Baumgartner, M.R., Yudkoff, M., Zielonka, M., Hoffmann, G.F., Burgard, P., Schulze, A., McCandless, S.E., Garcia-Cazorla, A., Seminara, J., Garbade, S.F., & Kölker, S. (Jul 2019). Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders. Ann Neurol, 86, 116-128. doi:10.1002/ana.25492 |
| F.6478 |
Urea Cycle Disorders Consortium, Buerger, C., Garbade, S.F., Dietrich Alber, F., Waisbren, S.E., McCarter, R., Kölker, S., & Burgard, P. (Mar 2019). Impairment of cognitive function in ornithine transcarbamylase deficiency is global rather than domain-specific and is associated with disease onset, sex, maximum ammonium, and number of hyperammonemic events. J Inherit Metab Dis, 42, 243-253. doi:10.1002/jimd.12013 |
| F.6477 |
Valayannopoulos, V., Boddaert, N., Mention, K., Touati, G., Barbier, V., Chabli, A., Sedel, F., Kaplan, J., Dufier, J.L., Seidenwurm, D., Rabier, D., Saudubray, J.M., & de Lonlay, P. (Jun 2009). Secondary creatine deficiency in ornithine delta-aminotransferase deficiency. Mol Genet Metab, 97, 109-13. doi:10.1016/j.ymgme.2008.12.010 |
| F.7889 |
Valle, D., & Kaiser-Kupfer, M. (1982). Gyrate atrophy of the choroid and retina. Prog Clin Biol Res, 82:123-34. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7051021 |
| F.6334 |
Valle, D., Walser, M., Brusilow, S., Kaiser-Kupfer, M.I., & Takki, K. (Apr 1981). Gyrate atrophy of the choroid and retina. Biochemical considerations and experience with an arginine-restricted diet. Ophthalmology, 88, 325-30. doi:10.1016/s0161-6420(81)35028-3 |
| F.6335 |
Valle, D., Walser, M., Brusilow, S.W., & Kaiser-Kupfer, M. (Feb 1980). Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet. J Clin Invest, 65, 371-8. doi:10.1172/JCI109680 |
| F.5982 |
Van de Bor, M., Mooy, P., van Zoeren, D., Berger, R., van Gelderen, H.H., & Teijema, H.L. (Dec 1984). Successful treatment of severe carbamyl phosphate synthetase I deficiency. Arch Dis Child, 59, 1183-5. doi:10.1136/adc.59.12.1183 |
| F.5979 |
van Karnebeek, C.D., Sly, W.S., Ross, C.J., Salvarinova, R., Yaplito-Lee, J., Santra, S., Shyr, C., Horvath, G.A., Eydoux, P., Lehman, A.M., Bernard, V., Newlove, T., Ukpeh, H., Chakrapani, A., Preece, M.A., Ball, S., Pitt, J., Vallance, H.D., Coulter-Mackie, M., Nguyen, H., Zhang, L.H., Bhavsar, A.P., Sinclair, G., Waheed, A., Wasserman, W.W., & Stockler-Ipsiroglu, S. (Mar 2014). Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. Am J Hum Genet, 94, 453-61. doi:10.1016/j.ajhg.2014.01.006 |
| F.6470 |
Vannas-Sulonen, K., Simell, O., & Sipilä, I. (Nov 1987). Gyrate atrophy of the choroid and retina. The ocular disease progresses in juvenile patients despite normal or near normal plasma ornithine concentration. Ophthalmology, 94(11):1428-33. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3684217 |
| F.5975 |
Vannas-Sulonen, K., Sipilä, I., Vannas, A., Simell, O., & Rapola, J. (Dec 1985). Gyrate atrophy of the choroid and retina. A five-year follow-up of creatine supplementation. Ophthalmology, 92, 1719-27. doi:10.1016/s0161-6420(85)34098-8 |
| F.5973 |
Vara, R., Dhawan, A., Deheragoda, M., Grünewald, S., Pierre, G., Heaton, N.D., Vilca-Melendez, H., & Hadžić, N. (Jun 2018). Liver transplantation for neonatal-onset citrullinemia. Pediatr Transplant, 22, e13191. doi:10.1111/petr.13191 |
| F.6468 |
Vargha, R., Möslinger, D., Wagner, O., & Golej, J. (Jan 2012). Venovenous hemodiafiltration and hypothermia for treatment of cerebral edema associated with hyperammonemia. Indian Pediatr, 49(1):60-2. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22318103 |
| F.6467 |
Vasudevan, A.K., Shanmugam, N.P., Rammohan, A., & Rela, M. (Dec 2022). Managing recurrent portal steal in auxiliary liver transplantation for non-cirrhotic metabolic liver disease. Pediatr Transplant, 26, e14389. doi:10.1111/petr.14389 |
| F.6465 |
Venkateswaran, L., Scaglia, F., McLin, V., Hertel, P., Shchelochkov, O.A., Karpen, S., Mahoney, D., & Yee, D.L. (Jul 2009). Ornithine transcarbamylase deficiency: a possible risk factor for thrombosis. Pediatr Blood Cancer, 53, 100-2. doi:10.1002/pbc.22016 |
| F.6463 |
Vockley, J., Vockley, C.M., Lin, S.P., Tuchman, M., Wu, T.C., Lin, C.Y., & Seashore, M.R. (Feb 1992). Normal N-acetylglutamate concentration measured in liver from a new patient with N-acetylglutamate synthetase deficiency: physiologic and biochemical implications. Biochem Med Metab Biol, 47, 38-46. doi:10.1016/0885-4505(92)90006-k |
| F.5830 |
Wakiya, T., Sanada, Y., Mizuta, K., Umehara, M., Urahasi, T., Egami, S., Hishikawa, S., Fujiwara, T., Sakuma, Y., Hyodo, M., Murayama, K., Hakamada, K., Yasuda, Y., & Kawarasaki, H. (Jun 2011). Living donor liver transplantation for ornithine transcarbamylase deficiency. Pediatr Transplant, 15, 390-5. doi:10.1111/j.1399-3046.2011.01494.x |
| F.7894 |
Wang, M., Zhao, X.Y., Wang, Y., Wang, X.M., Yazaki, M., Saheki, T., Jia, J.D., Zhang, C.H., Ou, X.J., & Wang, T.L. (Apr 2022). Adult-onset type II citrullinemia manifested as hepatosteatosis or steatohepatitis: A report of three Chinese cases. J Dig Dis, 23, 240-245. doi:10.1111/1751-2980.13096 |
| F.5956 |
Watanabe, Y., Numakura, C., Tahara, T., Fukui, K., Torimura, T., Hiromatsu, Y., Tomotsune, K., Yamakawa, M., & Hayasaka, K. (Jun 2020). Diabetes mellitus exacerbates citrin deficiency via glucose toxicity. Diabetes Res Clin Pract, 164, 108159. doi:10.1016/j.diabres.2020.108159 |
| F.5951 |
Weleber, R.G., & Kennaway, N.G. (Apr 1981). Clinical trial of vitamin B6 for gyrate atrophy of the choroid and retina. Ophthalmology, 88, 316-24. doi:10.1016/s0161-6420(81)35035-0 |
| F.7265 |
Wells, D.L., Thomas, J.B., Sacks, G.S., & Zouhary, L.A. (2014). Late-onset urea cycle disorder in adulthood unmasked by severe malnutrition. Nutrition, 30, 943-7. doi:10.1016/j.nut.2013.12.011 |
| F.5946 |
Wendel, U., Wieland, J., Bremer, H.J., & Bachmann, C. (Jan 1989). Ornithine transcarbamylase deficiency in a male: strict correlation between metabolic control and plasma arginine concentration. Eur J Pediatr, 148, 349-52. doi:10.1007/BF00444132 |
| F.6338 |
Wilcken, B. (Apr 2004). Problems in the management of urea cycle disorders. Mol Genet Metab, 81 Suppl 1, S86-91. doi:10.1016/j.ymgme.2003.10.016 |
| F.5937 |
Wilcox, G. (Mar 2018). Impact of pregnancy on inborn errors of metabolism. Rev Endocr Metab Disord, 19, 13-33. doi:10.1007/s11154-018-9455-2 |
| F.5932 |
Wilnai, Y., Blumenfeld, Y.J., Cusmano, K., Hintz, S.R., Alcorn, D., Benitz, W.E., Berquist, W.E., Bernstein, J.A., Castillo, R.O., Concepcion, W., Cowan, T.M., Cox, K.L., Lyell, D.J., Esquivel, C.O., Homeyer, M., Hudgins, L., Hurwitz, M., Palma, J.P., Schelley, S., Akula, V.P., Summar, M.L., & Enns, G.M. (Mar 2018). Prenatal treatment of ornithine transcarbamylase deficiency. Mol Genet Metab, 123, 297-300. doi:10.1016/j.ymgme.2018.01.004 |
| F.5931 |
Wilson, C.J., Lee, P.J., & Leonard, J.V. (Dec 2001). Plasma glutamine and ammonia concentrations in ornithine carbamoyltransferase deficiency and citrullinaemia. J Inherit Metab Dis, 24, 691-5. doi:10.1023/a:1012995701589 |
| F.7891 |
Wiltshire, E.J., Poplawski, N.K., Harbord, M.G., Harrison, R.J., & Fletcher, J.M. (Dec 2000). Ornithine carbamoyltransferase deficiency presenting with chorea in a female. J Inherit Metab Dis, 23, 843-4. doi:10.1023/a:1026768904395 |
| F.5923 |
Wong, L.J., Craigen, W.J., & O'Brien, W.E. (Feb 1994). Postpartum coma and death due to carbamoyl-phosphate synthetase I deficiency. Ann Intern Med, 120, 216-7. doi:10.7326/0003-4819-120-3-199402010-00007 |
| F.6424 |
Wood, G.E., & McNicholas, J. (May 2015). Coma query cause. BMJ Case Rep, 2015, . doi:10.1136/bcr-2014-205592 |
| F.7282 |
Wykowski, J., Keller, C., & Kucybala, K. (Jan 2022). Adult-Onset Type 1 Citrullinemia Presenting as Postpartum Acute Liver Failure. Am J Med, 135, e22-e23. doi:10.1016/j.amjmed.2021.08.024 |
| F.6341 |
Yajima, Y., Hirasawa, T., & Saheki, T. (Jun 1982). Diurnal fluctuation of blood ammonia levels in adult-type citrullinemia. Tohoku J Exp Med, 137, 213-20. doi:10.1620/tjem.137.213 |
| F.6345 |
Yamamoto, S., Yamashita, S., Kakiuchi, T., Kurogi, K., Nishi, T.M., Tago, M., & Yamashita, S.I. (Nov 2022). Late-Onset Ornithine Transcarbamylase Deficiency Complicated with Extremely High Serum Ammonia Level: Prompt Induction of Hemodialysis as the Key to Successful Treatment. Am J Case Rep, 23, e937658. doi:10.12659/AJCR.937658 |
| F.5854 |
Yankol, Y., Mecit, N., Kanmaz, T., Acarli, K., & Kalayoglu, M. (Oct 2017). Argininosuccinic Aciduria-A Rare Indication for Liver Transplant: Report of Two Cases. Exp Clin Transplant, 15, 581-584. doi:10.6002/ect.2015.0078 |
| F.5860 |
Yazaki, M., Hashikura, Y., Takei, Y., Ikegami, T., Miyagawa, S., Yamamoto, K., Tokuda, T., Kobayashi, K., Saheki, T., & Ikeda, S. (Apr 2004). Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia. Liver Transpl, 10, 550-4. doi:10.1002/lt.20131 |
| F.7284 |
Yokoi, T., Honke, K., Funabashi, T., Hayashi, R., Suzuki, Y., Taniguchi, N., Hosoya, M., & Saheki, T. (Dec 1981). Partial ornithine transcarbamylase deficiency simulating Reye syndrome. J Pediatr, 99, 929-31. doi:10.1016/s0022-3476(81)80025-x |
| F.5873 |
Yoshida, R., Sasaki, T., Sunouchi, T., Ueda, M., Kitamura, M., Nakayama, T., Saito, J., & Imafuku, I. (Oct 2021). Neuromyelitis Optica Complicated by Ornithine Transcarbamylase Deficiency Treated Safely with Pulse Steroid Therapy. Intern Med, 60, 3321-3324. doi:10.2169/internalmedicine.6885-20 |
| F.5879 |
Yu, L., Rayhill, S.C., Hsu, E.K., & Landis, C.S. (Oct 2015). Liver Transplantation for Urea Cycle Disorders: Analysis of the United Network for Organ Sharing Database. Transplant Proc, 47, 2413-8. doi:10.1016/j.transproceed.2015.09.020 |
| F.7286 |
Yudkoff, M., Yang, W., Snodgrass, P.J., & Segal, S. (Mar 1980). Ornithine transcarbamylase deficiency in a boy with normal development. J Pediatr, 96, 441-3. doi:10.1016/s0022-3476(80)80694-9 |
| F.5890 |
Zekušić, M., Škaričić, A., Fumić, K., Rogić, D., Žigman, T., Petković Ramadža, D., Vukojević, N., Rüfenacht, V., Uroić, V., & Barić, I. (Oct 2018). Metabolic follow-up of a Croatian patient with gyrate atrophy and a new mutation in the gene: a case report. Biochem Med (Zagreb), 28, 030801. doi:10.11613/BM.2018.030801 |
| F.5891 |
Zeltner, N.A., Welsink-Karssies, M.M., Landolt, M.A., Bosshard-Bullinger, D., Keller, F., Bosch, A.M., Groenendijk, M., Grünert, S.C., Karall, D., Rettenbacher, B., Scholl-Bürgi, S., Baumgartner, M.R., & Huemer, M. (Nov 2019). Reducing complexity: explaining inborn errors of metabolism and their treatment to children and adolescents. Orphanet J Rare Dis, 14, 248. doi:10.1186/s13023-019-1236-9 |
| F.6452 |
Zhang, Y., Landau, Y.E., Miller, D.T., Marsden, D., Berry, G.T., & Kellogg, M.D. (Dec 2012). Recurrent unexplained hyperammonemia in an adolescent with arginase deficiency. Clin Biochem, 45, 1583-6. doi:10.1016/j.clinbiochem.2012.08.015 |
| F.5910 |
Zhou, Q., Huang, H., Ma, L., & Zhu, T. (2020). The Application of Next-Generation Sequencing (NGS) in Neonatal-Onset Urea Cycle Disorders (UCDs): Clinical Course, Metabolomic Profiling, and Genetic Findings in Nine Chinese Hyperammonemia Patients. Biomed Res Int, 2020, 5690915. doi:10.1155/2020/5690915 |
| F.5915 |
Zimmer, K.P., Naim, H.Y., Koch, H.G., Colombo, J.P., Rossi, R., Schmid, K.W., Deufel, T., Ullrich, K., & Harms, E. (Dec 1995). Survival after early treatment for carbamyl phosphate synthetase (CPS) I deficiency associated with increase of intramitochondrial CPS I. Lancet, 346, 1530-1. doi:10.1016/s0140-6736(95)92055-2 |
| F.5917 |
Ziogas, I.A., Wu, W.K., Matsuoka, L.K., Pai, A.K., Hafberg, E.T., Gillis, L.A., Morgan, T.M., & Alexopoulos, S.P. (Dec 2021). Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time. Liver Transpl, 27, 1799-1810. doi:10.1002/lt.26186 |
| F.5257 |
Şeker-Yılmaz, B., Kör, D., Tümgör, G., Ceylaner, S., & Önenli-Mungan, N. (2017). p.Val452Ile mutation of the SLC25A13 gene in a Turkish patient with citrin deficiency. Turk J Pediatr, 59, 311-314. doi:10.24953/turkjped.2017.03.012 |
